#mentalhealthresearch — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #mentalhealthresearch, aggregated by home.social.
-
DATE: May 19, 2026 at 06:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Brain connectivity predicts how well antidepressants work compared to placebos
People seeking treatment for depression often experience symptom relief whether they receive an active medication or an inactive placebo. By pooling data from various symptom surveys, researchers discovered that while the pattern of mood improvement looks remarkably similar in both scenarios, the active medication triggers a more intense recovery that is uniquely linked to a patient’s baseline brain connectivity. These findings were published in the journal Psychological Medicine.
Measuring mood improvement is notoriously difficult. Clinicians typically rely on standard questionnaires that condense a wide range of symptoms into a single score. This approach can blur the lines between different aspects of mental health, such as sadness, anxiety, and suicidal thoughts. It also makes it difficult to separate the effects of a pharmacological drug from the placebo effect.
The placebo effect occurs when a patient’s condition improves simply because they expect the treatment to work. Past studies comparing antidepressants to placebos often show little statistical difference when using broad, conventional rating scales. When patients take a pill, the expectation of feeling better often drives real neurobiological changes. To understand the true effect of a drug, researchers need tools that can distinguish the unique benefits of the medication from the baseline response generated by the mind.
Lucie Berkovitch, a researcher in the Department of Psychiatry at the Yale University School of Medicine, led a team to investigate this measurement problem. The researchers suspected that standard clinical evaluations were hiding subtle differences between pharmacological and placebo responses. They wanted to know if the underlying pattern of symptom relief was the same for both groups. They also sought to determine if an individual’s brain wiring before treatment could predict their chance of recovery.
To answer these questions, the team analyzed data from a past clinical trial involving 192 individuals with major depressive disorder. In the first phase of this trial, patients were randomly assigned to receive either a common antidepressant medication called sertraline or a placebo pill for eight weeks. The original trial researchers had collected detailed information on the patients’ depression, anxiety, suicidal thoughts, and manic symptoms. They also took magnetic resonance imaging scans of the patients’ brains before any treatment began.
During the trial, clinicians used a simple seven-point rating system called the Clinical Global Impressions scale to judge if patients were getting better. Based on this broad assessment, the original results showed no statistical difference between the sertraline and placebo groups. The percentage of people considered responders to the treatment was nearly identical between the active drug and the sugar pill.
Berkovitch and the team approached the data differently. They used a statistical technique to evaluate the responses across all the individual questions from four separate psychological surveys. Instead of just looking at the final scores calculated by doctors, the researchers let a computer algorithm find the most dominant pattern of change across 73 individual symptom questions. This data-driven approach compressed the wide variety of patient answers into a single mathematical dimension of clinical improvement.
The results revealed that patients in both the medication and placebo groups improved along the exact same path. Whether they received the active drug or the sugar pill, their symptom relief followed a shared geometry. The mathematical type of symptoms that changed over time remained consistent regardless of the pill they took.
However, the patients taking sertraline advanced much further along this path. The mathematical model showed that the antidepressant prompted a stronger overall recovery than the placebo. This heightened effect was driven largely by greater reductions in anxiety and a lower risk of suicidal thoughts.
This finding highlighted the limitations of the classic clinician rating scale. The basic seven-point assessment had failed to detect this difference in response intensity. Standard surveys often weigh physical symptoms heavily, which can obscure specific psychological improvements tracked by the mathematical model.
The team also looked at the patients’ symptoms at the start of the study to see if initial sickness levels could predict recovery. They found that severe anxiety and suicidal risk at baseline predicted larger improvements on the mathematical model for both groups. Conversely, high baseline scores specifically for depression only predicted recovery in the patients taking sertraline.
After the first eight weeks, the trial included a second phase where patients who did not show improvement were switched to new treatments. Nonresponders to the placebo received sertraline, and nonresponders to sertraline received bupropion, a different class of antidepressant. The researchers ran the mathematical model on this second phase and found the same shared pattern of improvement. This outcome suggests the symptom geometry is consistent even as medications change.
The researchers achieved their most revealing insights when analyzing the baseline brain scans. During a resting state scan, a machine measures how different areas of the brain communicate with one another while the patient is awake but not performing any specific task. The researchers mapped the global connectivity of the brain. They identified how strongly each small region was linked to the rest of the neural network.
They found that higher overall brain connectivity before treatment predicted a stronger recovery on the symptom model for patients taking the antidepressant. This meant that the biological setup of a patient’s brain could forecast how well they would respond to the actual medication. This forecasting effect was not statistically significant for the patients who received the placebo.
Specific networks within the brain also showed different predictive patterns. The connectivity of the amygdala, an almond-shaped cluster of neurons involved in processing fear and emotion, predicted symptom improvement across both groups. The broader overarching brain networks only correlated with the medical drug’s success. The pharmacological treatment appeared to target specific, reproducible brain circuits. The biological roots of the placebo effect proved to be noisier and harder to predict than the drug response.
The study relies on a secondary analysis of a previously completed trial, meaning the data was not collected specifically for this new mathematical approach. The sample size was relatively small for the type of statistical modeling used. Additionally, the original trial design did not include brain scans taken at the end of the eight-week treatment period. Without follow-up imaging, investigators could only observe what predicted recovery rather than seeing how the brain physically changed in response to the drug or the placebo.
Future research featuring larger groups of patients could help confirm if this single path of mood improvement holds true across different demographics and depression subtypes. Conducting new trials that include multiple scans over time would allow scientists to map how these neural networks actually reorganize as symptoms fade. Comparing different types of antidepressants side-by-side using the same computer modeling could reveal how different chemical mechanisms influence recovery. By refining how we measure the mind, doctors may eventually be able to use brain scans to match patients with the most effective personalized treatments.
The study, “A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns,” was authored by Lucie Berkovitch, Kangjoo Lee, Jie Ji, Markus Helmer, Masih Rahmati, Jure Demsar, Aleksij Kraljic, Andraz Matkovic, Zailyn Tamayo, John Murray, Grega Repovs, John Krystal, William Martin, Clara Fonteneau, and Alan Anticevic.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #BrainConnectivity #DepressionTreatment #SertralineVsPlacebo #Antidepressants #PlaceboEffect #Neuroimaging #RestingState fMRI #MentalHealthResearch #PersonalizedMedicine #PsychologicalMedicine
-
DATE: May 19, 2026 at 10:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Brain scans reveal how ibogaine alters neural networks in veterans with head trauma
Special Operations veterans suffering from traumatic brain injuries and posttraumatic stress disorder experienced notable improvements in their symptoms after a single dose of the psychoactive drug ibogaine. Brain scans revealed that the therapy was associated with persistent increases in cerebral blood flow and the widespread reorganization of neural networks. The research was published in the journal Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Sudden blows to the head or intense blast exposures cause traumatic brain injuries. Combat zones expose soldiers to blast waves that send immense pressure through the skull, which can stretch or shear delicate nerve fibers. Chronic effects include severe anxiety, depression, and a reduced capacity to perform routine tasks.
Special Operations forces veterans experience incredibly high rates of both brain injuries and stress disorders compared to the civilian population. Standard medical treatments rely heavily on regular talk therapy and symptom management medications. Many veterans do not find relief through these traditional routes.
New, restorative medical approaches are actively sought by health agencies to help former service members regain their independence. Derived from a shrub native to Central Africa, ibogaine is a naturally occurring hallucinogenic compound. The substance has a long history of use in spiritual ceremonies by the Bwiti religion in Gabon.
In recent years, researchers have analyzed the drug as a potential treatment for addiction and psychiatric conditions. It represents a highly active field of study as psychologists seek alternative medicines for treatment-resistant patients. Once inside the body, ibogaine is rapidly converted into an active byproduct that lingers for an extended period.
This secondary chemical bathes the brain in small proteins over the course of several days. These particular proteins help the organ build fresh neural connections and repair damaged tissue. This physical remodeling process is known to scientists as neuroplasticity.
Severe impacts to the head often damage blood vessels, heavily reducing the local supply of energy across the cortex. Starvation at a cellular level often leads to cognitive decay well before physical tissue loss becomes obvious on a standard medical scan. Reversing this drop in blood supply is a primary physiological goal for recovering a healthy mind after a physical injury.
Lead authors Malvika Sridhar and Azeezat Azeez, along with senior authors Manish Saggar and Nolan R. Williams of Stanford University, wanted to see how the medicinal compound physically altered the human brain. They built on a previous trial wherein veterans showed extraordinary clinical improvements after receiving ibogaine combined with an intravenous dose of magnesium.
The magnesium was included to protect the cardiovascular system against rhythmic risks commonly associated with the psychedelic agent. While the veterans reported feeling much better mentally and physically after the trial therapy, the underlying brain changes remained a mystery.
To understand the biological mechanisms, the team tracked thirty male combat veterans who voluntarily enrolled at a clinic in Mexico. The participants all had mild to moderate head traumas. Most of the veterans also met the diagnostic criteria for severe posttraumatic stress disorder.
The researchers used functional magnetic resonance imaging to capture detailed pictures of the participants’ brains. Participants were scanned at three different points in time. The first scan occurred before the treatment began, establishing a biological baseline.
The second brain scan took place immediately after the medication session ended. A final scan was administered a full month later to look for durable physiological effects. The overall imaging process utilized two distinct tracking techniques to map cerebral activity.
One scanning method tracked the flow of freshly oxygenated blood through the intricate vessels of the brain. The scientists achieved this by magnetically tagging the water molecules in the blood just before they reached the skull. Active brain cells require more oxygen, making localized blood flow a reliable indicator of healthy brain function.
The second imaging method measured how different regions of the organ communicate with one another. This was recorded while the veterans were resting quietly and staring blankly at a screen. When one region of the brain consistently consumes oxygen at the exact same rhythm as a distant region, scientists assume the two areas are tied together in a functional network.
The blood flow measurements yielded evidence of sustained metabolic changes. One month after the therapy, the veterans displayed gradual increases in blood flow across several key areas of the brain. The increases were particularly concentrated in the cortex, the striatum, and the limbic system.
The limbic system is an inner ring of brain tissue heavily involved in processing emotions and forming memories. These psychological functions are frequently disrupted by combat-related head trauma. The metabolic shifts hinted at a return to healthier neural states.
Specific spikes in blood flow were found in the anterior cingulate cortex and the left insula. The insula helps individuals process their internal physical states and plays a heavy role in personal motivation. Increased blood flow in these two regions directly corresponded to the veterans’ reported improvements in their daily living.
Psychologists quantified those improvements using an expansive symptom questionnaire designed by the World Health Organization. Veterans with the most blood flow directed to the insula experienced the greatest functional recovery. They reported enhanced ease with physical mobility and navigating regular domestic life activities.
The researchers also observed an extensive restructuring of functional brain networks. Communication patterns between different brain regions shifted substantially following the single dose of ibogaine. The modifications spread across networks responsible for attention, sensory processing, and idle thought.
A notable reduction in connectivity appeared between the amygdala and the medial prefrontal cortex. The amygdala acts as the brain’s emotional core and fear center. In individuals traumatized by combat, hyperactive connections between the amygdala and prefrontal cortex are associated with emotional dysregulation.
The experimental therapy appeared to dampen this reactive circuitry, possibly reducing severe emotional responses to bad memories. Another shifting connection occurred between the hippocampus and the dorsal attention network.
The hippocampus coordinates memory consolidation, while the dorsal attention network helps maintain focused goals. Traumatic injuries commonly impair both memory retention and cognitive focus. The new communication pathway between these regions held steady a full month after the clinical treatment.
Other changes emerged across sensory processing areas of the organ. The putamen, a region which affects motor control and language, received a higher volume of blood flow. The salience network, responsible for filtering important emotional stimuli from background noise, also featured shifting connections.
The broader neuroscience community hypothesizes that psychedelic compounds relax the rigid control systems of the brain. Under this theoretical model, deeply ingrained patterns of thought are temporarily loosened. This liberation allows the brain to process old traumas from flexible perspectives, which might explain the widespread network reorganization seen in the data.
The study opens the door to deeper neurobiological investigations, but it has distinct limitations. The sample size was relatively small and consisted entirely of middle-aged male combat veterans. The lack of diversity means the findings may not apply to the wider public or to individuals with different types of head injuries.
The trial was observational and did not include a protective placebo component. All participants knew they were receiving the active substance, which can influence how they report their symptoms. The veterans also sustained multiple brain injuries over their combat careers, complicating efforts to pinpoint the exact physical origins of their trauma.
Evaluating these outcomes further requires larger numbers of participants and strict control groups. To verify these initial observations, scientists need to evaluate patients who receive an inactive placebo alongside those who receive the actual therapeutic drug. Until then, these early scans provide a foundational map of how ibogaine altered a severely injured human brain.
The study, “Neural Correlates of Ibogaine: Evidence From Functional Neuroimaging of Military Veterans,” was authored by Malvika Sridhar, Azeezat Azeez, Andrew D. Geoly, Jennifer I. Lissemore, Afik Faerman, Kirsten Cherian, Derrick M. Buchanan, Saron Hunegnaw, Jackob N. Keynan, Ian H. Kratter, Cammie Rolle, Manish Saggar, and Nolan R. Williams.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #IbogaineTherapy #TraumaticBrainInjury #PTSDRecovery #Neuroplasticity #BrainImaging #FunctionalMRI #CerebralBloodFlow #VeteransHealth #Neuroscience #MentalHealthResearch
-
DATE: May 19, 2026 at 10:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Brain scans reveal how ibogaine alters neural networks in veterans with head trauma
Special Operations veterans suffering from traumatic brain injuries and posttraumatic stress disorder experienced notable improvements in their symptoms after a single dose of the psychoactive drug ibogaine. Brain scans revealed that the therapy was associated with persistent increases in cerebral blood flow and the widespread reorganization of neural networks. The research was published in the journal Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Sudden blows to the head or intense blast exposures cause traumatic brain injuries. Combat zones expose soldiers to blast waves that send immense pressure through the skull, which can stretch or shear delicate nerve fibers. Chronic effects include severe anxiety, depression, and a reduced capacity to perform routine tasks.
Special Operations forces veterans experience incredibly high rates of both brain injuries and stress disorders compared to the civilian population. Standard medical treatments rely heavily on regular talk therapy and symptom management medications. Many veterans do not find relief through these traditional routes.
New, restorative medical approaches are actively sought by health agencies to help former service members regain their independence. Derived from a shrub native to Central Africa, ibogaine is a naturally occurring hallucinogenic compound. The substance has a long history of use in spiritual ceremonies by the Bwiti religion in Gabon.
In recent years, researchers have analyzed the drug as a potential treatment for addiction and psychiatric conditions. It represents a highly active field of study as psychologists seek alternative medicines for treatment-resistant patients. Once inside the body, ibogaine is rapidly converted into an active byproduct that lingers for an extended period.
This secondary chemical bathes the brain in small proteins over the course of several days. These particular proteins help the organ build fresh neural connections and repair damaged tissue. This physical remodeling process is known to scientists as neuroplasticity.
Severe impacts to the head often damage blood vessels, heavily reducing the local supply of energy across the cortex. Starvation at a cellular level often leads to cognitive decay well before physical tissue loss becomes obvious on a standard medical scan. Reversing this drop in blood supply is a primary physiological goal for recovering a healthy mind after a physical injury.
Lead authors Malvika Sridhar and Azeezat Azeez, along with senior authors Manish Saggar and Nolan R. Williams of Stanford University, wanted to see how the medicinal compound physically altered the human brain. They built on a previous trial wherein veterans showed extraordinary clinical improvements after receiving ibogaine combined with an intravenous dose of magnesium.
The magnesium was included to protect the cardiovascular system against rhythmic risks commonly associated with the psychedelic agent. While the veterans reported feeling much better mentally and physically after the trial therapy, the underlying brain changes remained a mystery.
To understand the biological mechanisms, the team tracked thirty male combat veterans who voluntarily enrolled at a clinic in Mexico. The participants all had mild to moderate head traumas. Most of the veterans also met the diagnostic criteria for severe posttraumatic stress disorder.
The researchers used functional magnetic resonance imaging to capture detailed pictures of the participants’ brains. Participants were scanned at three different points in time. The first scan occurred before the treatment began, establishing a biological baseline.
The second brain scan took place immediately after the medication session ended. A final scan was administered a full month later to look for durable physiological effects. The overall imaging process utilized two distinct tracking techniques to map cerebral activity.
One scanning method tracked the flow of freshly oxygenated blood through the intricate vessels of the brain. The scientists achieved this by magnetically tagging the water molecules in the blood just before they reached the skull. Active brain cells require more oxygen, making localized blood flow a reliable indicator of healthy brain function.
The second imaging method measured how different regions of the organ communicate with one another. This was recorded while the veterans were resting quietly and staring blankly at a screen. When one region of the brain consistently consumes oxygen at the exact same rhythm as a distant region, scientists assume the two areas are tied together in a functional network.
The blood flow measurements yielded evidence of sustained metabolic changes. One month after the therapy, the veterans displayed gradual increases in blood flow across several key areas of the brain. The increases were particularly concentrated in the cortex, the striatum, and the limbic system.
The limbic system is an inner ring of brain tissue heavily involved in processing emotions and forming memories. These psychological functions are frequently disrupted by combat-related head trauma. The metabolic shifts hinted at a return to healthier neural states.
Specific spikes in blood flow were found in the anterior cingulate cortex and the left insula. The insula helps individuals process their internal physical states and plays a heavy role in personal motivation. Increased blood flow in these two regions directly corresponded to the veterans’ reported improvements in their daily living.
Psychologists quantified those improvements using an expansive symptom questionnaire designed by the World Health Organization. Veterans with the most blood flow directed to the insula experienced the greatest functional recovery. They reported enhanced ease with physical mobility and navigating regular domestic life activities.
The researchers also observed an extensive restructuring of functional brain networks. Communication patterns between different brain regions shifted substantially following the single dose of ibogaine. The modifications spread across networks responsible for attention, sensory processing, and idle thought.
A notable reduction in connectivity appeared between the amygdala and the medial prefrontal cortex. The amygdala acts as the brain’s emotional core and fear center. In individuals traumatized by combat, hyperactive connections between the amygdala and prefrontal cortex are associated with emotional dysregulation.
The experimental therapy appeared to dampen this reactive circuitry, possibly reducing severe emotional responses to bad memories. Another shifting connection occurred between the hippocampus and the dorsal attention network.
The hippocampus coordinates memory consolidation, while the dorsal attention network helps maintain focused goals. Traumatic injuries commonly impair both memory retention and cognitive focus. The new communication pathway between these regions held steady a full month after the clinical treatment.
Other changes emerged across sensory processing areas of the organ. The putamen, a region which affects motor control and language, received a higher volume of blood flow. The salience network, responsible for filtering important emotional stimuli from background noise, also featured shifting connections.
The broader neuroscience community hypothesizes that psychedelic compounds relax the rigid control systems of the brain. Under this theoretical model, deeply ingrained patterns of thought are temporarily loosened. This liberation allows the brain to process old traumas from flexible perspectives, which might explain the widespread network reorganization seen in the data.
The study opens the door to deeper neurobiological investigations, but it has distinct limitations. The sample size was relatively small and consisted entirely of middle-aged male combat veterans. The lack of diversity means the findings may not apply to the wider public or to individuals with different types of head injuries.
The trial was observational and did not include a protective placebo component. All participants knew they were receiving the active substance, which can influence how they report their symptoms. The veterans also sustained multiple brain injuries over their combat careers, complicating efforts to pinpoint the exact physical origins of their trauma.
Evaluating these outcomes further requires larger numbers of participants and strict control groups. To verify these initial observations, scientists need to evaluate patients who receive an inactive placebo alongside those who receive the actual therapeutic drug. Until then, these early scans provide a foundational map of how ibogaine altered a severely injured human brain.
The study, “Neural Correlates of Ibogaine: Evidence From Functional Neuroimaging of Military Veterans,” was authored by Malvika Sridhar, Azeezat Azeez, Andrew D. Geoly, Jennifer I. Lissemore, Afik Faerman, Kirsten Cherian, Derrick M. Buchanan, Saron Hunegnaw, Jackob N. Keynan, Ian H. Kratter, Cammie Rolle, Manish Saggar, and Nolan R. Williams.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #IbogaineTherapy #TraumaticBrainInjury #PTSDRecovery #Neuroplasticity #BrainImaging #FunctionalMRI #CerebralBloodFlow #VeteransHealth #Neuroscience #MentalHealthResearch
-
DATE: May 19, 2026 at 10:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Brain scans reveal how ibogaine alters neural networks in veterans with head trauma
Special Operations veterans suffering from traumatic brain injuries and posttraumatic stress disorder experienced notable improvements in their symptoms after a single dose of the psychoactive drug ibogaine. Brain scans revealed that the therapy was associated with persistent increases in cerebral blood flow and the widespread reorganization of neural networks. The research was published in the journal Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Sudden blows to the head or intense blast exposures cause traumatic brain injuries. Combat zones expose soldiers to blast waves that send immense pressure through the skull, which can stretch or shear delicate nerve fibers. Chronic effects include severe anxiety, depression, and a reduced capacity to perform routine tasks.
Special Operations forces veterans experience incredibly high rates of both brain injuries and stress disorders compared to the civilian population. Standard medical treatments rely heavily on regular talk therapy and symptom management medications. Many veterans do not find relief through these traditional routes.
New, restorative medical approaches are actively sought by health agencies to help former service members regain their independence. Derived from a shrub native to Central Africa, ibogaine is a naturally occurring hallucinogenic compound. The substance has a long history of use in spiritual ceremonies by the Bwiti religion in Gabon.
In recent years, researchers have analyzed the drug as a potential treatment for addiction and psychiatric conditions. It represents a highly active field of study as psychologists seek alternative medicines for treatment-resistant patients. Once inside the body, ibogaine is rapidly converted into an active byproduct that lingers for an extended period.
This secondary chemical bathes the brain in small proteins over the course of several days. These particular proteins help the organ build fresh neural connections and repair damaged tissue. This physical remodeling process is known to scientists as neuroplasticity.
Severe impacts to the head often damage blood vessels, heavily reducing the local supply of energy across the cortex. Starvation at a cellular level often leads to cognitive decay well before physical tissue loss becomes obvious on a standard medical scan. Reversing this drop in blood supply is a primary physiological goal for recovering a healthy mind after a physical injury.
Lead authors Malvika Sridhar and Azeezat Azeez, along with senior authors Manish Saggar and Nolan R. Williams of Stanford University, wanted to see how the medicinal compound physically altered the human brain. They built on a previous trial wherein veterans showed extraordinary clinical improvements after receiving ibogaine combined with an intravenous dose of magnesium.
The magnesium was included to protect the cardiovascular system against rhythmic risks commonly associated with the psychedelic agent. While the veterans reported feeling much better mentally and physically after the trial therapy, the underlying brain changes remained a mystery.
To understand the biological mechanisms, the team tracked thirty male combat veterans who voluntarily enrolled at a clinic in Mexico. The participants all had mild to moderate head traumas. Most of the veterans also met the diagnostic criteria for severe posttraumatic stress disorder.
The researchers used functional magnetic resonance imaging to capture detailed pictures of the participants’ brains. Participants were scanned at three different points in time. The first scan occurred before the treatment began, establishing a biological baseline.
The second brain scan took place immediately after the medication session ended. A final scan was administered a full month later to look for durable physiological effects. The overall imaging process utilized two distinct tracking techniques to map cerebral activity.
One scanning method tracked the flow of freshly oxygenated blood through the intricate vessels of the brain. The scientists achieved this by magnetically tagging the water molecules in the blood just before they reached the skull. Active brain cells require more oxygen, making localized blood flow a reliable indicator of healthy brain function.
The second imaging method measured how different regions of the organ communicate with one another. This was recorded while the veterans were resting quietly and staring blankly at a screen. When one region of the brain consistently consumes oxygen at the exact same rhythm as a distant region, scientists assume the two areas are tied together in a functional network.
The blood flow measurements yielded evidence of sustained metabolic changes. One month after the therapy, the veterans displayed gradual increases in blood flow across several key areas of the brain. The increases were particularly concentrated in the cortex, the striatum, and the limbic system.
The limbic system is an inner ring of brain tissue heavily involved in processing emotions and forming memories. These psychological functions are frequently disrupted by combat-related head trauma. The metabolic shifts hinted at a return to healthier neural states.
Specific spikes in blood flow were found in the anterior cingulate cortex and the left insula. The insula helps individuals process their internal physical states and plays a heavy role in personal motivation. Increased blood flow in these two regions directly corresponded to the veterans’ reported improvements in their daily living.
Psychologists quantified those improvements using an expansive symptom questionnaire designed by the World Health Organization. Veterans with the most blood flow directed to the insula experienced the greatest functional recovery. They reported enhanced ease with physical mobility and navigating regular domestic life activities.
The researchers also observed an extensive restructuring of functional brain networks. Communication patterns between different brain regions shifted substantially following the single dose of ibogaine. The modifications spread across networks responsible for attention, sensory processing, and idle thought.
A notable reduction in connectivity appeared between the amygdala and the medial prefrontal cortex. The amygdala acts as the brain’s emotional core and fear center. In individuals traumatized by combat, hyperactive connections between the amygdala and prefrontal cortex are associated with emotional dysregulation.
The experimental therapy appeared to dampen this reactive circuitry, possibly reducing severe emotional responses to bad memories. Another shifting connection occurred between the hippocampus and the dorsal attention network.
The hippocampus coordinates memory consolidation, while the dorsal attention network helps maintain focused goals. Traumatic injuries commonly impair both memory retention and cognitive focus. The new communication pathway between these regions held steady a full month after the clinical treatment.
Other changes emerged across sensory processing areas of the organ. The putamen, a region which affects motor control and language, received a higher volume of blood flow. The salience network, responsible for filtering important emotional stimuli from background noise, also featured shifting connections.
The broader neuroscience community hypothesizes that psychedelic compounds relax the rigid control systems of the brain. Under this theoretical model, deeply ingrained patterns of thought are temporarily loosened. This liberation allows the brain to process old traumas from flexible perspectives, which might explain the widespread network reorganization seen in the data.
The study opens the door to deeper neurobiological investigations, but it has distinct limitations. The sample size was relatively small and consisted entirely of middle-aged male combat veterans. The lack of diversity means the findings may not apply to the wider public or to individuals with different types of head injuries.
The trial was observational and did not include a protective placebo component. All participants knew they were receiving the active substance, which can influence how they report their symptoms. The veterans also sustained multiple brain injuries over their combat careers, complicating efforts to pinpoint the exact physical origins of their trauma.
Evaluating these outcomes further requires larger numbers of participants and strict control groups. To verify these initial observations, scientists need to evaluate patients who receive an inactive placebo alongside those who receive the actual therapeutic drug. Until then, these early scans provide a foundational map of how ibogaine altered a severely injured human brain.
The study, “Neural Correlates of Ibogaine: Evidence From Functional Neuroimaging of Military Veterans,” was authored by Malvika Sridhar, Azeezat Azeez, Andrew D. Geoly, Jennifer I. Lissemore, Afik Faerman, Kirsten Cherian, Derrick M. Buchanan, Saron Hunegnaw, Jackob N. Keynan, Ian H. Kratter, Cammie Rolle, Manish Saggar, and Nolan R. Williams.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #IbogaineTherapy #TraumaticBrainInjury #PTSDRecovery #Neuroplasticity #BrainImaging #FunctionalMRI #CerebralBloodFlow #VeteransHealth #Neuroscience #MentalHealthResearch
-
DATE: May 16, 2026 at 08:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Brain reactions to fearful faces predict psychiatric hospitalization risk
URL: https://www.psypost.org/brain-reactions-to-fearful-faces-predict-psychiatric-hospitalization-risk/
People living with major depressive disorder or bipolar disorder who show heightened brain activity when viewing fearful faces possess an elevated risk of psychiatric hospitalization within a year. A complementary tendency to recognize negative facial expressions more rapidly than positive ones also tracks with this heightened vulnerability. These findings emerged from a recent study published in the journal Neuropsychopharmacology.
Major depression and bipolar disorder represent two of the most common and persistent mood disorders globally. Both health conditions can severely disrupt a person’s life and sometimes lead to periods marked by intense psychological distress. The economic costs to society are immense, stemming from impaired occupational functioning and the need for intensive medical treatments. When symptoms escalate rapidly, individuals may require psychiatric inpatient hospital care for stabilization and safety.
Predicting who might experience these severe relapses remains a massive challenge for medical professionals. Clinicians usually rely on a patient’s medical history, current symptom severity, and medication status to estimate their risk for future hospitalization. Mental health specialists suspect that deeper biological and psychological markers could offer much better clues about a patient’s long-term trajectory. A prominent area of interest involves how the brain processes emotional information over time.
People with mood disorders often exhibit subtle differences in the way they interpret the social world around them. Previous research has linked depression and bipolar disorder to increased activity in the amygdala, a small structure deep within the brain that acts as a primary alarm system for detecting threats. Similarly, the fusiform gyrus, a brain region dedicated to recognizing faces, often works in overdrive when individuals with these health conditions view emotional expressions.
This elevated brain activity is thought to create a negative cognitive bias. Experts believe that inadequate regulation by the prefrontal cortex allows the amygdala to overreact to benign situations. This dysregulation leads individuals to perceive neutral social interactions as hostile or upsetting. The constant misinterpretation of social cues can maintain a depressed mood or trigger heightened anxiety.
To explore whether these neurological traits predict long-term clinical outcomes, a team led by Kamilla W. Miskowiak conducted an investigation. Miskowiak is a professor and clinical psychologist at the University of Copenhagen and the Mental Health Services in the Capital Region of Denmark. Her collaborative team sought to determine if a patient’s neurological and behavioral responses to faces could forecast their likelihood of severe health incidents. They suspected that heightened threat sensitivity might compromise psychological resilience and leave people vulnerable to sudden symptom spikes.
The research team recruited 112 participants who had previously been diagnosed with either major depressive disorder or bipolar disorder. At the start of the investigation, the participants underwent tests to assess their mental state and gather baseline recordings of their emotional reactivity. The researchers utilized functional magnetic resonance imaging, a technology that measures changes in blood flow to observe brain activity in real time. Inside the machine, the participants laid still while viewing a series of photographs depicting happy or fearful human faces shown for mere fractions of a second.
While the scanner recorded their brain activity, the participants pressed buttons to indicate the gender of the person in each photograph. This task allowed the scientists to record continuous unconscious reactions within the participants’ amygdala and fusiform gyrus without the subjects actively thinking about the emotions shown. Outside the scanner, the participants completed an additional behavioral assessment on a standard computer. This secondary test required them to recognize a morphing facial expression as sadness, fear, anger, disgust, surprise, or happiness.
The computer program steadily increased the intensity of the emotional expressions during the testing phase. The participants were instructed to identify the emotion as quickly and accurately as possible by tapping labeled keys on a keyboard. Following the initial testing phase, the researchers tracked the participants for one entire year using the Danish national health registries. These comprehensive population databases keep extensive, centralized records of all hospital admissions and medical diagnoses across the country.
By analyzing the registry data, the team could precisely identify which subjects ended up admitted to a psychiatric hospital during the twelve months after their brain scans. Only inpatient hospitalizations strictly tied to mood episodes were counted in the final data. When reviewing the clinical timelines, the scientists discovered an association between excessive brain activation and subsequent inpatient care. Patients who displayed higher levels of activity in the left amygdala when looking at fearful faces experienced a much higher rate of admission to psychiatric facilities.
The registry results showed that a proportional increase in left amygdala reactivity equated to a roughly three percent higher average probability of needing hospital therapy. Other brain regions evaluated in the scan, like the right amygdala and the left or right fusiform gyrus, did not display a statistically significant relationship with future hospital visits. The behavioral data from the computer tests provided parallel insights into the patients’ mental vulnerabilities. Individuals who recognized negative faces faster than they recognized positive faces faced a noticeably higher risk of needing hospitalization.
For every slight increase in this face recognition speed metric, the participants experienced an approximate three and a half percent bump in their average baseline danger of admission. The accuracy with which they identified the specific emotions, however, yielded results that were not statistically significant in relation to future psychiatric visits. Miskowiak and her colleagues propose that these specific neural and behavioral markers indicate a hyperactive stress response system. An exaggerated sensitivity to threats might exhaust a person’s coping mechanisms over several months.
Without adequate mental regulation, constant negative perceptions could easily exacerbate depressive or manic episodes until they reach an emergency threshold. The researchers emphasize that the tests highlight a potential vulnerability profile rather than an underlying mechanism that spontaneously triggers an episode. The study provides novel prognostic insights, but it comes with a few limitations that warrant consideration. Out of the 112 participants monitored throughout the year, only 20 individuals ultimately required psychiatric hospitalization.
This modest number of serious clinical events means that larger validation studies are necessary to confirm the exact patterns of risk. The participant group also included people taking a wide variety of psychotropic medications, which might have influenced individual brain responses in subtle ways. Because the research relied entirely on observational data from health registries, the design cannot determine if the negative cognitive biases directly provoke the hospitalizations. The associations simply indicate that exaggerated threat responses tend to coincide with poorer clinical outcomes.
The researchers also combined patients with major depressive disorder and bipolar disorder into a single group to maintain sufficient statistical power. Future work might separate these populations to see if the predictive biomarkers act differently depending on the specific diagnosis. Moving forward, the scientists hope to explore whether these threat-processing markers can actively guide therapeutic decisions in clinics. If clinicians can identify patients with high amygdala reactivity early on, they might be able to offer more targeted interventions.
Preventative psychological therapies designed to reduce negative cognitive biases could theoretically lower the overall disease burden for the highest-risk populations. Modifying the way these brains process emotional information might ultimately keep more patients safe and out of emergency psychiatric wards.
The study, “Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders,” was authored by Kamilla W. Miskowiak, Brice Ozenne, Hanne L. Kjærstad, Patrick M. Fisher, Emily E. Beaman, Vibeke H. Dam, Alexander T. Ysbæk-Nielsen, Gitte M. Knudsen, Lars V. Kessing, Julian Macoveanu, Vibe G. Frøkjær, and Anjali Sankar.
URL: https://www.psypost.org/brain-reactions-to-fearful-faces-predict-psychiatric-hospitalization-risk/
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AmygdalaReactivity #ThreatProcessing #MoodDisorders #Depression #BipolarDisorder #FacialExpression #NegativeBias #PsychiatricHospitalization #Neuropsychopharmacology #MentalHealthResearch
-
DATE: May 16, 2026 at 08:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Brain reactions to fearful faces predict psychiatric hospitalization risk
URL: https://www.psypost.org/brain-reactions-to-fearful-faces-predict-psychiatric-hospitalization-risk/
People living with major depressive disorder or bipolar disorder who show heightened brain activity when viewing fearful faces possess an elevated risk of psychiatric hospitalization within a year. A complementary tendency to recognize negative facial expressions more rapidly than positive ones also tracks with this heightened vulnerability. These findings emerged from a recent study published in the journal Neuropsychopharmacology.
Major depression and bipolar disorder represent two of the most common and persistent mood disorders globally. Both health conditions can severely disrupt a person’s life and sometimes lead to periods marked by intense psychological distress. The economic costs to society are immense, stemming from impaired occupational functioning and the need for intensive medical treatments. When symptoms escalate rapidly, individuals may require psychiatric inpatient hospital care for stabilization and safety.
Predicting who might experience these severe relapses remains a massive challenge for medical professionals. Clinicians usually rely on a patient’s medical history, current symptom severity, and medication status to estimate their risk for future hospitalization. Mental health specialists suspect that deeper biological and psychological markers could offer much better clues about a patient’s long-term trajectory. A prominent area of interest involves how the brain processes emotional information over time.
People with mood disorders often exhibit subtle differences in the way they interpret the social world around them. Previous research has linked depression and bipolar disorder to increased activity in the amygdala, a small structure deep within the brain that acts as a primary alarm system for detecting threats. Similarly, the fusiform gyrus, a brain region dedicated to recognizing faces, often works in overdrive when individuals with these health conditions view emotional expressions.
This elevated brain activity is thought to create a negative cognitive bias. Experts believe that inadequate regulation by the prefrontal cortex allows the amygdala to overreact to benign situations. This dysregulation leads individuals to perceive neutral social interactions as hostile or upsetting. The constant misinterpretation of social cues can maintain a depressed mood or trigger heightened anxiety.
To explore whether these neurological traits predict long-term clinical outcomes, a team led by Kamilla W. Miskowiak conducted an investigation. Miskowiak is a professor and clinical psychologist at the University of Copenhagen and the Mental Health Services in the Capital Region of Denmark. Her collaborative team sought to determine if a patient’s neurological and behavioral responses to faces could forecast their likelihood of severe health incidents. They suspected that heightened threat sensitivity might compromise psychological resilience and leave people vulnerable to sudden symptom spikes.
The research team recruited 112 participants who had previously been diagnosed with either major depressive disorder or bipolar disorder. At the start of the investigation, the participants underwent tests to assess their mental state and gather baseline recordings of their emotional reactivity. The researchers utilized functional magnetic resonance imaging, a technology that measures changes in blood flow to observe brain activity in real time. Inside the machine, the participants laid still while viewing a series of photographs depicting happy or fearful human faces shown for mere fractions of a second.
While the scanner recorded their brain activity, the participants pressed buttons to indicate the gender of the person in each photograph. This task allowed the scientists to record continuous unconscious reactions within the participants’ amygdala and fusiform gyrus without the subjects actively thinking about the emotions shown. Outside the scanner, the participants completed an additional behavioral assessment on a standard computer. This secondary test required them to recognize a morphing facial expression as sadness, fear, anger, disgust, surprise, or happiness.
The computer program steadily increased the intensity of the emotional expressions during the testing phase. The participants were instructed to identify the emotion as quickly and accurately as possible by tapping labeled keys on a keyboard. Following the initial testing phase, the researchers tracked the participants for one entire year using the Danish national health registries. These comprehensive population databases keep extensive, centralized records of all hospital admissions and medical diagnoses across the country.
By analyzing the registry data, the team could precisely identify which subjects ended up admitted to a psychiatric hospital during the twelve months after their brain scans. Only inpatient hospitalizations strictly tied to mood episodes were counted in the final data. When reviewing the clinical timelines, the scientists discovered an association between excessive brain activation and subsequent inpatient care. Patients who displayed higher levels of activity in the left amygdala when looking at fearful faces experienced a much higher rate of admission to psychiatric facilities.
The registry results showed that a proportional increase in left amygdala reactivity equated to a roughly three percent higher average probability of needing hospital therapy. Other brain regions evaluated in the scan, like the right amygdala and the left or right fusiform gyrus, did not display a statistically significant relationship with future hospital visits. The behavioral data from the computer tests provided parallel insights into the patients’ mental vulnerabilities. Individuals who recognized negative faces faster than they recognized positive faces faced a noticeably higher risk of needing hospitalization.
For every slight increase in this face recognition speed metric, the participants experienced an approximate three and a half percent bump in their average baseline danger of admission. The accuracy with which they identified the specific emotions, however, yielded results that were not statistically significant in relation to future psychiatric visits. Miskowiak and her colleagues propose that these specific neural and behavioral markers indicate a hyperactive stress response system. An exaggerated sensitivity to threats might exhaust a person’s coping mechanisms over several months.
Without adequate mental regulation, constant negative perceptions could easily exacerbate depressive or manic episodes until they reach an emergency threshold. The researchers emphasize that the tests highlight a potential vulnerability profile rather than an underlying mechanism that spontaneously triggers an episode. The study provides novel prognostic insights, but it comes with a few limitations that warrant consideration. Out of the 112 participants monitored throughout the year, only 20 individuals ultimately required psychiatric hospitalization.
This modest number of serious clinical events means that larger validation studies are necessary to confirm the exact patterns of risk. The participant group also included people taking a wide variety of psychotropic medications, which might have influenced individual brain responses in subtle ways. Because the research relied entirely on observational data from health registries, the design cannot determine if the negative cognitive biases directly provoke the hospitalizations. The associations simply indicate that exaggerated threat responses tend to coincide with poorer clinical outcomes.
The researchers also combined patients with major depressive disorder and bipolar disorder into a single group to maintain sufficient statistical power. Future work might separate these populations to see if the predictive biomarkers act differently depending on the specific diagnosis. Moving forward, the scientists hope to explore whether these threat-processing markers can actively guide therapeutic decisions in clinics. If clinicians can identify patients with high amygdala reactivity early on, they might be able to offer more targeted interventions.
Preventative psychological therapies designed to reduce negative cognitive biases could theoretically lower the overall disease burden for the highest-risk populations. Modifying the way these brains process emotional information might ultimately keep more patients safe and out of emergency psychiatric wards.
The study, “Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders,” was authored by Kamilla W. Miskowiak, Brice Ozenne, Hanne L. Kjærstad, Patrick M. Fisher, Emily E. Beaman, Vibeke H. Dam, Alexander T. Ysbæk-Nielsen, Gitte M. Knudsen, Lars V. Kessing, Julian Macoveanu, Vibe G. Frøkjær, and Anjali Sankar.
URL: https://www.psypost.org/brain-reactions-to-fearful-faces-predict-psychiatric-hospitalization-risk/
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AmygdalaReactivity #ThreatProcessing #MoodDisorders #Depression #BipolarDisorder #FacialExpression #NegativeBias #PsychiatricHospitalization #Neuropsychopharmacology #MentalHealthResearch
-
DATE: May 16, 2026 at 08:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Brain reactions to fearful faces predict psychiatric hospitalization risk
URL: https://www.psypost.org/brain-reactions-to-fearful-faces-predict-psychiatric-hospitalization-risk/
People living with major depressive disorder or bipolar disorder who show heightened brain activity when viewing fearful faces possess an elevated risk of psychiatric hospitalization within a year. A complementary tendency to recognize negative facial expressions more rapidly than positive ones also tracks with this heightened vulnerability. These findings emerged from a recent study published in the journal Neuropsychopharmacology.
Major depression and bipolar disorder represent two of the most common and persistent mood disorders globally. Both health conditions can severely disrupt a person’s life and sometimes lead to periods marked by intense psychological distress. The economic costs to society are immense, stemming from impaired occupational functioning and the need for intensive medical treatments. When symptoms escalate rapidly, individuals may require psychiatric inpatient hospital care for stabilization and safety.
Predicting who might experience these severe relapses remains a massive challenge for medical professionals. Clinicians usually rely on a patient’s medical history, current symptom severity, and medication status to estimate their risk for future hospitalization. Mental health specialists suspect that deeper biological and psychological markers could offer much better clues about a patient’s long-term trajectory. A prominent area of interest involves how the brain processes emotional information over time.
People with mood disorders often exhibit subtle differences in the way they interpret the social world around them. Previous research has linked depression and bipolar disorder to increased activity in the amygdala, a small structure deep within the brain that acts as a primary alarm system for detecting threats. Similarly, the fusiform gyrus, a brain region dedicated to recognizing faces, often works in overdrive when individuals with these health conditions view emotional expressions.
This elevated brain activity is thought to create a negative cognitive bias. Experts believe that inadequate regulation by the prefrontal cortex allows the amygdala to overreact to benign situations. This dysregulation leads individuals to perceive neutral social interactions as hostile or upsetting. The constant misinterpretation of social cues can maintain a depressed mood or trigger heightened anxiety.
To explore whether these neurological traits predict long-term clinical outcomes, a team led by Kamilla W. Miskowiak conducted an investigation. Miskowiak is a professor and clinical psychologist at the University of Copenhagen and the Mental Health Services in the Capital Region of Denmark. Her collaborative team sought to determine if a patient’s neurological and behavioral responses to faces could forecast their likelihood of severe health incidents. They suspected that heightened threat sensitivity might compromise psychological resilience and leave people vulnerable to sudden symptom spikes.
The research team recruited 112 participants who had previously been diagnosed with either major depressive disorder or bipolar disorder. At the start of the investigation, the participants underwent tests to assess their mental state and gather baseline recordings of their emotional reactivity. The researchers utilized functional magnetic resonance imaging, a technology that measures changes in blood flow to observe brain activity in real time. Inside the machine, the participants laid still while viewing a series of photographs depicting happy or fearful human faces shown for mere fractions of a second.
While the scanner recorded their brain activity, the participants pressed buttons to indicate the gender of the person in each photograph. This task allowed the scientists to record continuous unconscious reactions within the participants’ amygdala and fusiform gyrus without the subjects actively thinking about the emotions shown. Outside the scanner, the participants completed an additional behavioral assessment on a standard computer. This secondary test required them to recognize a morphing facial expression as sadness, fear, anger, disgust, surprise, or happiness.
The computer program steadily increased the intensity of the emotional expressions during the testing phase. The participants were instructed to identify the emotion as quickly and accurately as possible by tapping labeled keys on a keyboard. Following the initial testing phase, the researchers tracked the participants for one entire year using the Danish national health registries. These comprehensive population databases keep extensive, centralized records of all hospital admissions and medical diagnoses across the country.
By analyzing the registry data, the team could precisely identify which subjects ended up admitted to a psychiatric hospital during the twelve months after their brain scans. Only inpatient hospitalizations strictly tied to mood episodes were counted in the final data. When reviewing the clinical timelines, the scientists discovered an association between excessive brain activation and subsequent inpatient care. Patients who displayed higher levels of activity in the left amygdala when looking at fearful faces experienced a much higher rate of admission to psychiatric facilities.
The registry results showed that a proportional increase in left amygdala reactivity equated to a roughly three percent higher average probability of needing hospital therapy. Other brain regions evaluated in the scan, like the right amygdala and the left or right fusiform gyrus, did not display a statistically significant relationship with future hospital visits. The behavioral data from the computer tests provided parallel insights into the patients’ mental vulnerabilities. Individuals who recognized negative faces faster than they recognized positive faces faced a noticeably higher risk of needing hospitalization.
For every slight increase in this face recognition speed metric, the participants experienced an approximate three and a half percent bump in their average baseline danger of admission. The accuracy with which they identified the specific emotions, however, yielded results that were not statistically significant in relation to future psychiatric visits. Miskowiak and her colleagues propose that these specific neural and behavioral markers indicate a hyperactive stress response system. An exaggerated sensitivity to threats might exhaust a person’s coping mechanisms over several months.
Without adequate mental regulation, constant negative perceptions could easily exacerbate depressive or manic episodes until they reach an emergency threshold. The researchers emphasize that the tests highlight a potential vulnerability profile rather than an underlying mechanism that spontaneously triggers an episode. The study provides novel prognostic insights, but it comes with a few limitations that warrant consideration. Out of the 112 participants monitored throughout the year, only 20 individuals ultimately required psychiatric hospitalization.
This modest number of serious clinical events means that larger validation studies are necessary to confirm the exact patterns of risk. The participant group also included people taking a wide variety of psychotropic medications, which might have influenced individual brain responses in subtle ways. Because the research relied entirely on observational data from health registries, the design cannot determine if the negative cognitive biases directly provoke the hospitalizations. The associations simply indicate that exaggerated threat responses tend to coincide with poorer clinical outcomes.
The researchers also combined patients with major depressive disorder and bipolar disorder into a single group to maintain sufficient statistical power. Future work might separate these populations to see if the predictive biomarkers act differently depending on the specific diagnosis. Moving forward, the scientists hope to explore whether these threat-processing markers can actively guide therapeutic decisions in clinics. If clinicians can identify patients with high amygdala reactivity early on, they might be able to offer more targeted interventions.
Preventative psychological therapies designed to reduce negative cognitive biases could theoretically lower the overall disease burden for the highest-risk populations. Modifying the way these brains process emotional information might ultimately keep more patients safe and out of emergency psychiatric wards.
The study, “Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders,” was authored by Kamilla W. Miskowiak, Brice Ozenne, Hanne L. Kjærstad, Patrick M. Fisher, Emily E. Beaman, Vibeke H. Dam, Alexander T. Ysbæk-Nielsen, Gitte M. Knudsen, Lars V. Kessing, Julian Macoveanu, Vibe G. Frøkjær, and Anjali Sankar.
URL: https://www.psypost.org/brain-reactions-to-fearful-faces-predict-psychiatric-hospitalization-risk/
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AmygdalaReactivity #ThreatProcessing #MoodDisorders #Depression #BipolarDisorder #FacialExpression #NegativeBias #PsychiatricHospitalization #Neuropsychopharmacology #MentalHealthResearch
-
DATE: May 16, 2026 at 12:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Muscle strength linked to lower lifetime depression incidence in large new study
URL: https://www.psypost.org/handgrip-strength-linked-to-future-depression-risk-in-new-health-analysis/
A recent analysis of long-term health metrics reveals that adults with lower handgrip strength face a moderately higher risk of developing depression later in life. By pooling health information from nearly half a million people, an international team of researchers found that physical strength might serve as a broad, easily measurable indicator of resilience against certain mental health conditions. The findings were published in the Journal of Psychiatric Research.
Depression is a common mental health condition, affecting nearly four percent of the global population. Rates are slightly higher among older demographics. The disorder frequently co-occurs with physical ailments and can reduce a person’s overall life expectancy. Because the condition takes a heavy toll on individuals and society, health experts consistently look for ways to identify people who might be at an elevated risk.
One physiological marker that has gained attention in recent years is a person’s handgrip strength. Medical professionals measure this physical trait by asking an individual to squeeze a handheld device called a dynamometer with as much force as possible. Although it seems like a very specific, limited physical action, the amount of force a person can exert with their hand is a highly reliable measure of their overall muscular capacity. The measurement serves as a simplified window into how well the body maintains its functional muscle fibers.
Our total muscle mass naturally declines as we age, starting gradually as early as our forties. However, a steep drop in raw physical strength often reflects deeper physiological changes in the central nervous system, rather than just a simple loss of muscle tissue. The brain itself must consistently send powerful electrical signals to the limbs to generate force. Consequently, stronger grip test results generally correlate with a lower incidence of cardiovascular diseases, type 2 diabetes, and general mobility limitations that emerge in older adults.
Beyond keeping the body moving, muscular capacity also shows notable associations with human brain health. Some research connects higher physical strength to larger volumes in the hippocampus, a brain region heavily involved in memory and emotional regulation. People who perform well on strength assessments also tend to score higher on cognitive tests. This pattern suggests that physical robustness reflects an underlying health profile that ultimately protects the nervous system.
A number of past studies have highlighted a mathematical relationship between weak physical strength and current depressive symptoms. The primary issue with these prior investigations is that they relied on a cross-sectional study design. A cross-sectional observation takes a snapshot of a specific group at a single point in time. This methodology makes it impossible to know whether the physical weakness preceded the depression, or if the mental health disorder caused the individual to become less active and lose muscle mass.
To get a better sense of how this relationship unfolds over a longer time horizon, a team of researchers conducted a comprehensive review of existing scientific literature. The research team was led by Jênifer de Oliveira at the Federal University of Santa Maria in Brazil. They set out to see if baseline physical strength might predict the onset of new mood disorders in people who were completely free of depression at the start of observation.
The researchers utilized an analytical scientific technique known as a meta-analysis. In this type of study, scientists combine the numerical results of multiple independent projects to create one large, statistically powerful data set. For this specific analytical project, the team looked exclusively for prospective cohort studies. This specific type of research format follows a large group of people over an extended period, recording their baseline health metrics and simply waiting to see who develops certain clinical conditions in the future.
The authors queried major scientific databases for medical records that tracked both physical strength and mental health over observation periods lasting at least one entire year. Most importantly, the team restricted their analysis to participants who scored entirely below the threshold for depression on standardized clinical questionnaires at the start of the observation tracking period. This step was necessary to eliminate the chances of reverse causation. Reverse causation happens when an existing mood disorder is already causing a measurable decline in a person’s physical health before the baseline screening is taken.
Ultimately, the researchers identified sixteen eligible scientific articles drawing from twelve unique participant measurement cohorts across the globe. These distinct monitoring groups included individuals from countries such as China, Japan, Italy, England, Ireland, and South Africa. The combined data set included precisely 497,336 participants, with an average participant age hovering around sixty years. The total observation time added up to roughly 3.4 million person-years, a statistical metric representing the total number of people tracked multiplied by the consecutive years they were monitored.
The authors assessed the reliability of the underlying foundational data using a standardized clinical measurement tool called the Newcastle-Ottawa Scale. This academic rating system scores observational studies based on how exactly participants were initially selected and how thoroughly they were medically monitored over time. The average score across all the included research projects was an eight out of a possible nine points. This high mathematical score indicated that the foundational data utilized for the new, combined analysis was highly reliable.
When the researchers analyzed the combined numbers, they noticed a consistent historical pattern linking baseline capacity to future psychological outcomes. Individuals who scored lower on the dynamometer strength tests had a moderately higher likelihood of developing depressive symptoms later in life. Depending on the exact mathematical models used by the original research cohorts, the increased risk of developing depression hovered between 26 percent and 42 percent when directly comparing the weakest participants to the strongest participants.
Despite the mildly elevated risk observed in the data, the authors noted that the clinical impact on an individual patient level is relatively modest. The numerical results do not imply that weak hands directly cause the human brain to suddenly succumb to clinical depression. Instead, the scientists involved view the raw physical capacity measurement as a convenient proxy for a given person’s overall biological resilience. People with stronger results on the testing device are very likely engaging in far more daily physical activity throughout their continuous routines.
Regular physical movement is broadly known to protect the human nervous system. Routine bodily exercise promotes the rapid release of biochemical factors in the brain that help maintain healthy neural connections and hold off mental decline. Because grip capacity is deeply tied to how much a unique individual physically moves, the lower risk of depression might simply reflect the protective benefits of an active daily lifestyle. Stronger clinical participants might also harbor fewer unmeasured chronic diseases, giving them a vastly better overall systemic health profile.
The researchers also investigated why the mathematical differences varied somewhat from one specific study to the next. They used a statistical analysis tool called a meta-regression to test whether certain distinct demographic factors influenced the final outcomes. The researchers concluded that the moderating influence of variables like the percentage of women, the average age of the participants, and the societal prevalence of smoking was not statistically significant. However, the exact length of the overall observation period did play a specific mathematical role in the final data spread.
Academic tracking groups that continually followed their participants for an extensively long time showed slightly stronger correlations between low baseline strength and new depressive symptoms. The authors pointed out that the tangible medical influence of this extended time tracking was incredibly minimal in a practical sense. At the same time, the slight moderation points to a notable long-term aging trend. Over passing decades, an initial deficit in basic bodily capacity might continually signal a slowly growing vulnerability to broad systemic health declines, eventually taking a visible toll on psychological well-being.
The massive analysis does feature a few practical limitations that continually shape how the statistical results should be clinically interpreted. The primary researchers were completely unable to legally or mathematically account for how much specific exercise the participants voluntarily engaged in over the observation years. Many of the original historical data collection efforts simply did not track distinct daily movement routines around the clock. Without cleanly separating cardiovascular walking habits from isolated muscle strength, it remains fairly difficult to determine if lifting heavy weights distinctly averts psychological distress over the entire human lifespan.
The researchers also explicitly point out that their study framework could not possibly determine if a person’s complete unrecorded psychiatric history before the scientific study began eventually influenced their later depression risk. While enrolled participants were completely free of active depressive symptoms at the initial baseline measurement, some specific individuals may have experienced totally untreated episodes of severe depression much earlier in their personal lives.
The physical recurrence of past mental issues could have quietly skewed the baseline physical health metrics for certain people. The mathematical models also independently suggested that a uniquely small publication bias might exist across the academic literature, meaning medical studies showing absolutely no specific link might simply remain permanently unpublished.
For direct primary application, the authors continually caution against blindly using basic grip tests as an emergency screening tool in primary medical environments. Different independent research groups historically used wildly varying arbitrary cut-off points to define what specifically constituted weak physical capability, based entirely upon the unique bodily demographics of their specific global regions. Consequently, there is currently no standardized numerical threshold that could immediately alert primary medical professionals to a severely impending psychological crisis. General physical robustness should instead be properly viewed as a highly generalized population indicator of wider functional vulnerability.
Moving safely forward, the international research team actively suggests that future academic investigations intensively explore the daily household behavioral habits that organically link muscular power to psychological well-being. They practically recommend broadly conducting randomized controlled clinical trials to see if progressive resistance training regimens physically alter an aging participant’s likelihood of eventually developing a severe mood disorder. Such rigorous empirical evidence would properly clarify the biological mechanisms currently at play.
Until the desired trial results emerge naturally in the medical literature, voluntarily maintaining regular muscular capacity remains a completely sound societal recommendation for properly preserving basic biological function and organic psychological resilience as global populations age.
The study, “Association between handgrip strength and incident depression: a meta-analysis of prospective cohort studies,” was authored by Jênifer de Oliveira, Ismael Mignoni, Davy Vancampfort, Liye Zou, Brendon Stubbs, Aline Josiane Waclawovsky, and Felipe Barreto Schuch.
URL: https://www.psypost.org/handgrip-strength-linked-to-future-depression-risk-in-new-health-analysis/
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #HandgripStrength #DepressionRisk #MentalHealthResearch #MuscularResilience #AgingAndWellness #PhysicalActivityBenefits #GripStrengthCorrelation #LongevityHealth #BrainBodyConnection #PreventiveHealth
-
DATE: May 16, 2026 at 12:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Muscle strength linked to lower lifetime depression incidence in large new study
URL: https://www.psypost.org/handgrip-strength-linked-to-future-depression-risk-in-new-health-analysis/
A recent analysis of long-term health metrics reveals that adults with lower handgrip strength face a moderately higher risk of developing depression later in life. By pooling health information from nearly half a million people, an international team of researchers found that physical strength might serve as a broad, easily measurable indicator of resilience against certain mental health conditions. The findings were published in the Journal of Psychiatric Research.
Depression is a common mental health condition, affecting nearly four percent of the global population. Rates are slightly higher among older demographics. The disorder frequently co-occurs with physical ailments and can reduce a person’s overall life expectancy. Because the condition takes a heavy toll on individuals and society, health experts consistently look for ways to identify people who might be at an elevated risk.
One physiological marker that has gained attention in recent years is a person’s handgrip strength. Medical professionals measure this physical trait by asking an individual to squeeze a handheld device called a dynamometer with as much force as possible. Although it seems like a very specific, limited physical action, the amount of force a person can exert with their hand is a highly reliable measure of their overall muscular capacity. The measurement serves as a simplified window into how well the body maintains its functional muscle fibers.
Our total muscle mass naturally declines as we age, starting gradually as early as our forties. However, a steep drop in raw physical strength often reflects deeper physiological changes in the central nervous system, rather than just a simple loss of muscle tissue. The brain itself must consistently send powerful electrical signals to the limbs to generate force. Consequently, stronger grip test results generally correlate with a lower incidence of cardiovascular diseases, type 2 diabetes, and general mobility limitations that emerge in older adults.
Beyond keeping the body moving, muscular capacity also shows notable associations with human brain health. Some research connects higher physical strength to larger volumes in the hippocampus, a brain region heavily involved in memory and emotional regulation. People who perform well on strength assessments also tend to score higher on cognitive tests. This pattern suggests that physical robustness reflects an underlying health profile that ultimately protects the nervous system.
A number of past studies have highlighted a mathematical relationship between weak physical strength and current depressive symptoms. The primary issue with these prior investigations is that they relied on a cross-sectional study design. A cross-sectional observation takes a snapshot of a specific group at a single point in time. This methodology makes it impossible to know whether the physical weakness preceded the depression, or if the mental health disorder caused the individual to become less active and lose muscle mass.
To get a better sense of how this relationship unfolds over a longer time horizon, a team of researchers conducted a comprehensive review of existing scientific literature. The research team was led by Jênifer de Oliveira at the Federal University of Santa Maria in Brazil. They set out to see if baseline physical strength might predict the onset of new mood disorders in people who were completely free of depression at the start of observation.
The researchers utilized an analytical scientific technique known as a meta-analysis. In this type of study, scientists combine the numerical results of multiple independent projects to create one large, statistically powerful data set. For this specific analytical project, the team looked exclusively for prospective cohort studies. This specific type of research format follows a large group of people over an extended period, recording their baseline health metrics and simply waiting to see who develops certain clinical conditions in the future.
The authors queried major scientific databases for medical records that tracked both physical strength and mental health over observation periods lasting at least one entire year. Most importantly, the team restricted their analysis to participants who scored entirely below the threshold for depression on standardized clinical questionnaires at the start of the observation tracking period. This step was necessary to eliminate the chances of reverse causation. Reverse causation happens when an existing mood disorder is already causing a measurable decline in a person’s physical health before the baseline screening is taken.
Ultimately, the researchers identified sixteen eligible scientific articles drawing from twelve unique participant measurement cohorts across the globe. These distinct monitoring groups included individuals from countries such as China, Japan, Italy, England, Ireland, and South Africa. The combined data set included precisely 497,336 participants, with an average participant age hovering around sixty years. The total observation time added up to roughly 3.4 million person-years, a statistical metric representing the total number of people tracked multiplied by the consecutive years they were monitored.
The authors assessed the reliability of the underlying foundational data using a standardized clinical measurement tool called the Newcastle-Ottawa Scale. This academic rating system scores observational studies based on how exactly participants were initially selected and how thoroughly they were medically monitored over time. The average score across all the included research projects was an eight out of a possible nine points. This high mathematical score indicated that the foundational data utilized for the new, combined analysis was highly reliable.
When the researchers analyzed the combined numbers, they noticed a consistent historical pattern linking baseline capacity to future psychological outcomes. Individuals who scored lower on the dynamometer strength tests had a moderately higher likelihood of developing depressive symptoms later in life. Depending on the exact mathematical models used by the original research cohorts, the increased risk of developing depression hovered between 26 percent and 42 percent when directly comparing the weakest participants to the strongest participants.
Despite the mildly elevated risk observed in the data, the authors noted that the clinical impact on an individual patient level is relatively modest. The numerical results do not imply that weak hands directly cause the human brain to suddenly succumb to clinical depression. Instead, the scientists involved view the raw physical capacity measurement as a convenient proxy for a given person’s overall biological resilience. People with stronger results on the testing device are very likely engaging in far more daily physical activity throughout their continuous routines.
Regular physical movement is broadly known to protect the human nervous system. Routine bodily exercise promotes the rapid release of biochemical factors in the brain that help maintain healthy neural connections and hold off mental decline. Because grip capacity is deeply tied to how much a unique individual physically moves, the lower risk of depression might simply reflect the protective benefits of an active daily lifestyle. Stronger clinical participants might also harbor fewer unmeasured chronic diseases, giving them a vastly better overall systemic health profile.
The researchers also investigated why the mathematical differences varied somewhat from one specific study to the next. They used a statistical analysis tool called a meta-regression to test whether certain distinct demographic factors influenced the final outcomes. The researchers concluded that the moderating influence of variables like the percentage of women, the average age of the participants, and the societal prevalence of smoking was not statistically significant. However, the exact length of the overall observation period did play a specific mathematical role in the final data spread.
Academic tracking groups that continually followed their participants for an extensively long time showed slightly stronger correlations between low baseline strength and new depressive symptoms. The authors pointed out that the tangible medical influence of this extended time tracking was incredibly minimal in a practical sense. At the same time, the slight moderation points to a notable long-term aging trend. Over passing decades, an initial deficit in basic bodily capacity might continually signal a slowly growing vulnerability to broad systemic health declines, eventually taking a visible toll on psychological well-being.
The massive analysis does feature a few practical limitations that continually shape how the statistical results should be clinically interpreted. The primary researchers were completely unable to legally or mathematically account for how much specific exercise the participants voluntarily engaged in over the observation years. Many of the original historical data collection efforts simply did not track distinct daily movement routines around the clock. Without cleanly separating cardiovascular walking habits from isolated muscle strength, it remains fairly difficult to determine if lifting heavy weights distinctly averts psychological distress over the entire human lifespan.
The researchers also explicitly point out that their study framework could not possibly determine if a person’s complete unrecorded psychiatric history before the scientific study began eventually influenced their later depression risk. While enrolled participants were completely free of active depressive symptoms at the initial baseline measurement, some specific individuals may have experienced totally untreated episodes of severe depression much earlier in their personal lives.
The physical recurrence of past mental issues could have quietly skewed the baseline physical health metrics for certain people. The mathematical models also independently suggested that a uniquely small publication bias might exist across the academic literature, meaning medical studies showing absolutely no specific link might simply remain permanently unpublished.
For direct primary application, the authors continually caution against blindly using basic grip tests as an emergency screening tool in primary medical environments. Different independent research groups historically used wildly varying arbitrary cut-off points to define what specifically constituted weak physical capability, based entirely upon the unique bodily demographics of their specific global regions. Consequently, there is currently no standardized numerical threshold that could immediately alert primary medical professionals to a severely impending psychological crisis. General physical robustness should instead be properly viewed as a highly generalized population indicator of wider functional vulnerability.
Moving safely forward, the international research team actively suggests that future academic investigations intensively explore the daily household behavioral habits that organically link muscular power to psychological well-being. They practically recommend broadly conducting randomized controlled clinical trials to see if progressive resistance training regimens physically alter an aging participant’s likelihood of eventually developing a severe mood disorder. Such rigorous empirical evidence would properly clarify the biological mechanisms currently at play.
Until the desired trial results emerge naturally in the medical literature, voluntarily maintaining regular muscular capacity remains a completely sound societal recommendation for properly preserving basic biological function and organic psychological resilience as global populations age.
The study, “Association between handgrip strength and incident depression: a meta-analysis of prospective cohort studies,” was authored by Jênifer de Oliveira, Ismael Mignoni, Davy Vancampfort, Liye Zou, Brendon Stubbs, Aline Josiane Waclawovsky, and Felipe Barreto Schuch.
URL: https://www.psypost.org/handgrip-strength-linked-to-future-depression-risk-in-new-health-analysis/
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #HandgripStrength #DepressionRisk #MentalHealthResearch #MuscularResilience #AgingAndWellness #PhysicalActivityBenefits #GripStrengthCorrelation #LongevityHealth #BrainBodyConnection #PreventiveHealth
-
DATE: May 16, 2026 at 12:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Muscle strength linked to lower lifetime depression incidence in large new study
URL: https://www.psypost.org/handgrip-strength-linked-to-future-depression-risk-in-new-health-analysis/
A recent analysis of long-term health metrics reveals that adults with lower handgrip strength face a moderately higher risk of developing depression later in life. By pooling health information from nearly half a million people, an international team of researchers found that physical strength might serve as a broad, easily measurable indicator of resilience against certain mental health conditions. The findings were published in the Journal of Psychiatric Research.
Depression is a common mental health condition, affecting nearly four percent of the global population. Rates are slightly higher among older demographics. The disorder frequently co-occurs with physical ailments and can reduce a person’s overall life expectancy. Because the condition takes a heavy toll on individuals and society, health experts consistently look for ways to identify people who might be at an elevated risk.
One physiological marker that has gained attention in recent years is a person’s handgrip strength. Medical professionals measure this physical trait by asking an individual to squeeze a handheld device called a dynamometer with as much force as possible. Although it seems like a very specific, limited physical action, the amount of force a person can exert with their hand is a highly reliable measure of their overall muscular capacity. The measurement serves as a simplified window into how well the body maintains its functional muscle fibers.
Our total muscle mass naturally declines as we age, starting gradually as early as our forties. However, a steep drop in raw physical strength often reflects deeper physiological changes in the central nervous system, rather than just a simple loss of muscle tissue. The brain itself must consistently send powerful electrical signals to the limbs to generate force. Consequently, stronger grip test results generally correlate with a lower incidence of cardiovascular diseases, type 2 diabetes, and general mobility limitations that emerge in older adults.
Beyond keeping the body moving, muscular capacity also shows notable associations with human brain health. Some research connects higher physical strength to larger volumes in the hippocampus, a brain region heavily involved in memory and emotional regulation. People who perform well on strength assessments also tend to score higher on cognitive tests. This pattern suggests that physical robustness reflects an underlying health profile that ultimately protects the nervous system.
A number of past studies have highlighted a mathematical relationship between weak physical strength and current depressive symptoms. The primary issue with these prior investigations is that they relied on a cross-sectional study design. A cross-sectional observation takes a snapshot of a specific group at a single point in time. This methodology makes it impossible to know whether the physical weakness preceded the depression, or if the mental health disorder caused the individual to become less active and lose muscle mass.
To get a better sense of how this relationship unfolds over a longer time horizon, a team of researchers conducted a comprehensive review of existing scientific literature. The research team was led by Jênifer de Oliveira at the Federal University of Santa Maria in Brazil. They set out to see if baseline physical strength might predict the onset of new mood disorders in people who were completely free of depression at the start of observation.
The researchers utilized an analytical scientific technique known as a meta-analysis. In this type of study, scientists combine the numerical results of multiple independent projects to create one large, statistically powerful data set. For this specific analytical project, the team looked exclusively for prospective cohort studies. This specific type of research format follows a large group of people over an extended period, recording their baseline health metrics and simply waiting to see who develops certain clinical conditions in the future.
The authors queried major scientific databases for medical records that tracked both physical strength and mental health over observation periods lasting at least one entire year. Most importantly, the team restricted their analysis to participants who scored entirely below the threshold for depression on standardized clinical questionnaires at the start of the observation tracking period. This step was necessary to eliminate the chances of reverse causation. Reverse causation happens when an existing mood disorder is already causing a measurable decline in a person’s physical health before the baseline screening is taken.
Ultimately, the researchers identified sixteen eligible scientific articles drawing from twelve unique participant measurement cohorts across the globe. These distinct monitoring groups included individuals from countries such as China, Japan, Italy, England, Ireland, and South Africa. The combined data set included precisely 497,336 participants, with an average participant age hovering around sixty years. The total observation time added up to roughly 3.4 million person-years, a statistical metric representing the total number of people tracked multiplied by the consecutive years they were monitored.
The authors assessed the reliability of the underlying foundational data using a standardized clinical measurement tool called the Newcastle-Ottawa Scale. This academic rating system scores observational studies based on how exactly participants were initially selected and how thoroughly they were medically monitored over time. The average score across all the included research projects was an eight out of a possible nine points. This high mathematical score indicated that the foundational data utilized for the new, combined analysis was highly reliable.
When the researchers analyzed the combined numbers, they noticed a consistent historical pattern linking baseline capacity to future psychological outcomes. Individuals who scored lower on the dynamometer strength tests had a moderately higher likelihood of developing depressive symptoms later in life. Depending on the exact mathematical models used by the original research cohorts, the increased risk of developing depression hovered between 26 percent and 42 percent when directly comparing the weakest participants to the strongest participants.
Despite the mildly elevated risk observed in the data, the authors noted that the clinical impact on an individual patient level is relatively modest. The numerical results do not imply that weak hands directly cause the human brain to suddenly succumb to clinical depression. Instead, the scientists involved view the raw physical capacity measurement as a convenient proxy for a given person’s overall biological resilience. People with stronger results on the testing device are very likely engaging in far more daily physical activity throughout their continuous routines.
Regular physical movement is broadly known to protect the human nervous system. Routine bodily exercise promotes the rapid release of biochemical factors in the brain that help maintain healthy neural connections and hold off mental decline. Because grip capacity is deeply tied to how much a unique individual physically moves, the lower risk of depression might simply reflect the protective benefits of an active daily lifestyle. Stronger clinical participants might also harbor fewer unmeasured chronic diseases, giving them a vastly better overall systemic health profile.
The researchers also investigated why the mathematical differences varied somewhat from one specific study to the next. They used a statistical analysis tool called a meta-regression to test whether certain distinct demographic factors influenced the final outcomes. The researchers concluded that the moderating influence of variables like the percentage of women, the average age of the participants, and the societal prevalence of smoking was not statistically significant. However, the exact length of the overall observation period did play a specific mathematical role in the final data spread.
Academic tracking groups that continually followed their participants for an extensively long time showed slightly stronger correlations between low baseline strength and new depressive symptoms. The authors pointed out that the tangible medical influence of this extended time tracking was incredibly minimal in a practical sense. At the same time, the slight moderation points to a notable long-term aging trend. Over passing decades, an initial deficit in basic bodily capacity might continually signal a slowly growing vulnerability to broad systemic health declines, eventually taking a visible toll on psychological well-being.
The massive analysis does feature a few practical limitations that continually shape how the statistical results should be clinically interpreted. The primary researchers were completely unable to legally or mathematically account for how much specific exercise the participants voluntarily engaged in over the observation years. Many of the original historical data collection efforts simply did not track distinct daily movement routines around the clock. Without cleanly separating cardiovascular walking habits from isolated muscle strength, it remains fairly difficult to determine if lifting heavy weights distinctly averts psychological distress over the entire human lifespan.
The researchers also explicitly point out that their study framework could not possibly determine if a person’s complete unrecorded psychiatric history before the scientific study began eventually influenced their later depression risk. While enrolled participants were completely free of active depressive symptoms at the initial baseline measurement, some specific individuals may have experienced totally untreated episodes of severe depression much earlier in their personal lives.
The physical recurrence of past mental issues could have quietly skewed the baseline physical health metrics for certain people. The mathematical models also independently suggested that a uniquely small publication bias might exist across the academic literature, meaning medical studies showing absolutely no specific link might simply remain permanently unpublished.
For direct primary application, the authors continually caution against blindly using basic grip tests as an emergency screening tool in primary medical environments. Different independent research groups historically used wildly varying arbitrary cut-off points to define what specifically constituted weak physical capability, based entirely upon the unique bodily demographics of their specific global regions. Consequently, there is currently no standardized numerical threshold that could immediately alert primary medical professionals to a severely impending psychological crisis. General physical robustness should instead be properly viewed as a highly generalized population indicator of wider functional vulnerability.
Moving safely forward, the international research team actively suggests that future academic investigations intensively explore the daily household behavioral habits that organically link muscular power to psychological well-being. They practically recommend broadly conducting randomized controlled clinical trials to see if progressive resistance training regimens physically alter an aging participant’s likelihood of eventually developing a severe mood disorder. Such rigorous empirical evidence would properly clarify the biological mechanisms currently at play.
Until the desired trial results emerge naturally in the medical literature, voluntarily maintaining regular muscular capacity remains a completely sound societal recommendation for properly preserving basic biological function and organic psychological resilience as global populations age.
The study, “Association between handgrip strength and incident depression: a meta-analysis of prospective cohort studies,” was authored by Jênifer de Oliveira, Ismael Mignoni, Davy Vancampfort, Liye Zou, Brendon Stubbs, Aline Josiane Waclawovsky, and Felipe Barreto Schuch.
URL: https://www.psypost.org/handgrip-strength-linked-to-future-depression-risk-in-new-health-analysis/
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #HandgripStrength #DepressionRisk #MentalHealthResearch #MuscularResilience #AgingAndWellness #PhysicalActivityBenefits #GripStrengthCorrelation #LongevityHealth #BrainBodyConnection #PreventiveHealth
-
DATE: May 16, 2026 at 08:41AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists find hidden brain nutrient deficit that may fuel anxiety
URL: https://www.sciencedaily.com/releases/2026/05/260515234759.htm
A major analysis of brain scans found that people with anxiety disorders have noticeably lower levels of choline, a nutrient crucial for healthy brain function. The strongest evidence appeared in the prefrontal cortex, the region tied to emotional control and decision-making. Researchers say the discovery is the first clear chemical brain pattern linked to anxiety and could eventually lead to new nutrition-based treatments.
URL: https://www.sciencedaily.com/releases/2026/05/260515234759.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AnxietyNutrition #BrainHealth #Choline #PrefrontalCortex #MentalHealthResearch #Neuroscience #BrainDiet #NutritionForMentalHealth #AnxietyAwareness #HealthyBrain
-
DATE: May 16, 2026 at 08:41AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists find hidden brain nutrient deficit that may fuel anxiety
URL: https://www.sciencedaily.com/releases/2026/05/260515234759.htm
A major analysis of brain scans found that people with anxiety disorders have noticeably lower levels of choline, a nutrient crucial for healthy brain function. The strongest evidence appeared in the prefrontal cortex, the region tied to emotional control and decision-making. Researchers say the discovery is the first clear chemical brain pattern linked to anxiety and could eventually lead to new nutrition-based treatments.
URL: https://www.sciencedaily.com/releases/2026/05/260515234759.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AnxietyNutrition #BrainHealth #Choline #PrefrontalCortex #MentalHealthResearch #Neuroscience #BrainDiet #NutritionForMentalHealth #AnxietyAwareness #HealthyBrain
-
DATE: May 16, 2026 at 08:41AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists find hidden brain nutrient deficit that may fuel anxiety
URL: https://www.sciencedaily.com/releases/2026/05/260515234759.htm
A major analysis of brain scans found that people with anxiety disorders have noticeably lower levels of choline, a nutrient crucial for healthy brain function. The strongest evidence appeared in the prefrontal cortex, the region tied to emotional control and decision-making. Researchers say the discovery is the first clear chemical brain pattern linked to anxiety and could eventually lead to new nutrition-based treatments.
URL: https://www.sciencedaily.com/releases/2026/05/260515234759.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AnxietyNutrition #BrainHealth #Choline #PrefrontalCortex #MentalHealthResearch #Neuroscience #BrainDiet #NutritionForMentalHealth #AnxietyAwareness #HealthyBrain
-
DATE: May 13, 2026 at 09:07PM
SOURCE: SCIENCE DAILY PSYCHOLOGY FEEDTITLE: New psychedelic-like drugs could treat depression without making you trip
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
UC Davis researchers created brand-new psychedelic-like compounds by shining UV light on amino acid-based molecules. These compounds activated key serotonin receptors tied to brain plasticity and mental health benefits, but surprisingly did not cause hallucination-like behavior in animal tests. Scientists say the discovery could lead to future treatments for depression, PTSD, and addiction without the intense psychedelic experience.
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsychedelicLikeDrugs #DepressionTreatment #SerotoninReceptors #BrainPlasticity #MentalHealthResearch #NonPsychedelicTherapy #UC DavisScience #NovelTherapies #PTSDTreatment #AddictionRecovery
-
DATE: May 13, 2026 at 09:07PM
SOURCE: SCIENCE DAILY PSYCHOLOGY FEEDTITLE: New psychedelic-like drugs could treat depression without making you trip
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
UC Davis researchers created brand-new psychedelic-like compounds by shining UV light on amino acid-based molecules. These compounds activated key serotonin receptors tied to brain plasticity and mental health benefits, but surprisingly did not cause hallucination-like behavior in animal tests. Scientists say the discovery could lead to future treatments for depression, PTSD, and addiction without the intense psychedelic experience.
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsychedelicLikeDrugs #DepressionTreatment #SerotoninReceptors #BrainPlasticity #MentalHealthResearch #NonPsychedelicTherapy #UC DavisScience #NovelTherapies #PTSDTreatment #AddictionRecovery
-
DATE: May 13, 2026 at 09:07PM
SOURCE: SCIENCE DAILY PSYCHOLOGY FEEDTITLE: New psychedelic-like drugs could treat depression without making you trip
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
UC Davis researchers created brand-new psychedelic-like compounds by shining UV light on amino acid-based molecules. These compounds activated key serotonin receptors tied to brain plasticity and mental health benefits, but surprisingly did not cause hallucination-like behavior in animal tests. Scientists say the discovery could lead to future treatments for depression, PTSD, and addiction without the intense psychedelic experience.
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsychedelicLikeDrugs #DepressionTreatment #SerotoninReceptors #BrainPlasticity #MentalHealthResearch #NonPsychedelicTherapy #UC DavisScience #NovelTherapies #PTSDTreatment #AddictionRecovery
-
DATE: May 13, 2026 at 09:07PM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: New psychedelic-like drugs could treat depression without making you trip
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
UC Davis researchers created brand-new psychedelic-like compounds by shining UV light on amino acid-based molecules. These compounds activated key serotonin receptors tied to brain plasticity and mental health benefits, but surprisingly did not cause hallucination-like behavior in animal tests. Scientists say the discovery could lead to future treatments for depression, PTSD, and addiction without the intense psychedelic experience.
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #psychedeliclike #depressiontreatment #serotoninreceptors #brainplasticity #mentalhealthresearch #UCdavishalogen #noveltherapies #PTSDtreatment #addictionrecovery #depressionwithouttrip
-
DATE: May 13, 2026 at 09:07PM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: New psychedelic-like drugs could treat depression without making you trip
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
UC Davis researchers created brand-new psychedelic-like compounds by shining UV light on amino acid-based molecules. These compounds activated key serotonin receptors tied to brain plasticity and mental health benefits, but surprisingly did not cause hallucination-like behavior in animal tests. Scientists say the discovery could lead to future treatments for depression, PTSD, and addiction without the intense psychedelic experience.
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #psychedeliclike #depressiontreatment #serotoninreceptors #brainplasticity #mentalhealthresearch #UCdavishalogen #noveltherapies #PTSDtreatment #addictionrecovery #depressionwithouttrip
-
DATE: May 13, 2026 at 09:07PM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: New psychedelic-like drugs could treat depression without making you trip
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
UC Davis researchers created brand-new psychedelic-like compounds by shining UV light on amino acid-based molecules. These compounds activated key serotonin receptors tied to brain plasticity and mental health benefits, but surprisingly did not cause hallucination-like behavior in animal tests. Scientists say the discovery could lead to future treatments for depression, PTSD, and addiction without the intense psychedelic experience.
URL: https://www.sciencedaily.com/releases/2026/05/260512202325.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #psychedeliclike #depressiontreatment #serotoninreceptors #brainplasticity #mentalhealthresearch #UCdavishalogen #noveltherapies #PTSDtreatment #addictionrecovery #depressionwithouttrip
-
DATE: May 12, 2026 at 10:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Are the benefits of psychedelics exaggerated? A new study highlights the problem of selection bias
A study comparing psychedelic enthusiasts and people from the general population (who also had psychedelic experiences) found that the enthusiasts tended to report much greater positive quality-of-life effects. The enthusiasts also showed higher openness, extraversion, and agreeableness. This indicates that recruitment strategies in psychedelic research that lean towards including enthusiasts may shape the outcomes obtained in those studies. The paper was published in the Journal of Psychoactive Drugs.
Psychedelic drugs are substances that can strongly alter perception, mood, thinking, and the sense of self. They may change how people experience colors, sounds, time, memories, emotions, and the meaning of events. Classic psychedelics include LSD, psilocybin from “magic mushrooms,” DMT, and mescaline. These substances mainly act on serotonin receptors in the brain.
In research settings, psychedelics are being studied for possible therapeutic use in conditions such as depression, PTSD, anxiety, and substance use disorders. Their effects depend heavily on dose, personality, expectations, mental state, physical setting, and social support. Psychedelics can also carry risks, including panic, confusion, dangerous behavior during intoxication, worsening of some psychiatric conditions, and legal consequences where they are prohibited.
Study author Jonathan Bendz and his colleagues noted that many studies of psychedelic users report extraordinarily positive self-reported effects. However, they suggest that this might represent an exaggeration of the real effects caused by biased selection, or even self-selection, of study participants. The issue is that the effects of psychedelics can only be tested on individuals who agree to use them. These participants tend to be individuals who have already had especially positive experiences with psychedelic use.
To examine this hypothesis, these researchers conducted a study comparing whether the self-reported quality-of-life impact of psychedelic experiences differed between a convenience sample of psychedelic enthusiasts and a group of people from the general population recruited via Prolific. They also wanted to see whether the difference between the two groups remained after controlling for mindset, setting, motivation to use psychedelic drugs, and personality traits.
The enthusiast group consisted of 583 individuals recruited through an anonymous survey posted on the Facebook and Instagram pages of a Swedish nonprofit organization that disseminates information about psychedelic science (Nätverket för Psykedelisk Vetenskap). A snowball sampling approach was used to reach more participants. The general population group consisted of 599 individuals recruited via Prolific (an online survey platform). They were required to have prior psychedelic experience, but were not recruited from a specific psychedelic community.
Study participants completed assessments of the quality-of-life impact of their psychedelic experiences (e.g., “How has your most meaningful psychedelic experience affected the quality of your relationship with… family, friends, yourself, society, and nature?”). They also answered questions regarding their mindset and physical setting during the experience (“To what extent did you experience your mindset/environment to be optimal?”), their motivation (“What was your motivation for using a psychedelic substance?”), and their personality (using the IPIP-NEO-30 assessment).
Results showed that the psychedelic enthusiasts tended to report a much higher quality-of-life impact from their psychedelic experiences compared to the Prolific group. The enthusiast group also reported having a more optimal mindset and setting during their trips, and they were more likely to report taking the drugs for personal growth rather than for fun. Finally, the enthusiasts tended to be more open to new experiences, extraverted, and agreeable than the participants from the Prolific group.
Even after using a statistical model to account for these differences in personality, mindset, setting, and motivation, simply belonging to the enthusiast group remained the strongest predictor of reporting a high quality-of-life impact.
“As expected, participants recruited from an enthusiast-leaning channel reported considerably greater benefits [of psychedelic use] than those recruited from a general-population platform. Even after controlling for mindset, setting, motivation, and personality, sample membership remained the strongest predictor of quality-of-life impact,” the study authors concluded.
“The persistent effect of sample membership suggests that the two groups differ in additional ways not captured by our measures, for example in cultural expectations, social context, or demographic composition, shaping reported outcomes. These results underscore the need for caution when interpreting findings from psychedelic studies that rely on highly engaged user populations.”
The study sheds light on important methodological issues that studies of psychedelic effects face. However, the authors note some limitations. For example, the two groups had demographic differences; the general sample was overwhelmingly from the United States, while the enthusiast sample lacked country-of-residence data for most participants (though a portion resided in Sweden). This introduces the possibility of cross-cultural differences influencing the results.
Additionally, it should be noted that the Prolific sample likely included many psychedelic enthusiasts as well. Because of this, the difference between the two groups in this study likely underestimates the true difference between the general population and psychedelic enthusiasts.
The paper, “Selection Bias in Psychedelic Research: Comparing Self-Reported Quality-Of-Life Impact Between Enthusiasts and a General Population Sample,” was authored by Jonathan Bendz, Linus Schäfer, David Sjöström, Sverker Sikström, and Petri Kajonius.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Psychedelics #SelectionBias #QualityOfLife #PsychedelicResearch #StudyBias #OpenMindedness #PersonalityTraits #MentalHealthResearch #TherapeuticPsychedelics #ScientificCaution
-
DATE: May 12, 2026 at 10:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Are the benefits of psychedelics exaggerated? A new study highlights the problem of selection bias
A study comparing psychedelic enthusiasts and people from the general population (who also had psychedelic experiences) found that the enthusiasts tended to report much greater positive quality-of-life effects. The enthusiasts also showed higher openness, extraversion, and agreeableness. This indicates that recruitment strategies in psychedelic research that lean towards including enthusiasts may shape the outcomes obtained in those studies. The paper was published in the Journal of Psychoactive Drugs.
Psychedelic drugs are substances that can strongly alter perception, mood, thinking, and the sense of self. They may change how people experience colors, sounds, time, memories, emotions, and the meaning of events. Classic psychedelics include LSD, psilocybin from “magic mushrooms,” DMT, and mescaline. These substances mainly act on serotonin receptors in the brain.
In research settings, psychedelics are being studied for possible therapeutic use in conditions such as depression, PTSD, anxiety, and substance use disorders. Their effects depend heavily on dose, personality, expectations, mental state, physical setting, and social support. Psychedelics can also carry risks, including panic, confusion, dangerous behavior during intoxication, worsening of some psychiatric conditions, and legal consequences where they are prohibited.
Study author Jonathan Bendz and his colleagues noted that many studies of psychedelic users report extraordinarily positive self-reported effects. However, they suggest that this might represent an exaggeration of the real effects caused by biased selection, or even self-selection, of study participants. The issue is that the effects of psychedelics can only be tested on individuals who agree to use them. These participants tend to be individuals who have already had especially positive experiences with psychedelic use.
To examine this hypothesis, these researchers conducted a study comparing whether the self-reported quality-of-life impact of psychedelic experiences differed between a convenience sample of psychedelic enthusiasts and a group of people from the general population recruited via Prolific. They also wanted to see whether the difference between the two groups remained after controlling for mindset, setting, motivation to use psychedelic drugs, and personality traits.
The enthusiast group consisted of 583 individuals recruited through an anonymous survey posted on the Facebook and Instagram pages of a Swedish nonprofit organization that disseminates information about psychedelic science (Nätverket för Psykedelisk Vetenskap). A snowball sampling approach was used to reach more participants. The general population group consisted of 599 individuals recruited via Prolific (an online survey platform). They were required to have prior psychedelic experience, but were not recruited from a specific psychedelic community.
Study participants completed assessments of the quality-of-life impact of their psychedelic experiences (e.g., “How has your most meaningful psychedelic experience affected the quality of your relationship with… family, friends, yourself, society, and nature?”). They also answered questions regarding their mindset and physical setting during the experience (“To what extent did you experience your mindset/environment to be optimal?”), their motivation (“What was your motivation for using a psychedelic substance?”), and their personality (using the IPIP-NEO-30 assessment).
Results showed that the psychedelic enthusiasts tended to report a much higher quality-of-life impact from their psychedelic experiences compared to the Prolific group. The enthusiast group also reported having a more optimal mindset and setting during their trips, and they were more likely to report taking the drugs for personal growth rather than for fun. Finally, the enthusiasts tended to be more open to new experiences, extraverted, and agreeable than the participants from the Prolific group.
Even after using a statistical model to account for these differences in personality, mindset, setting, and motivation, simply belonging to the enthusiast group remained the strongest predictor of reporting a high quality-of-life impact.
“As expected, participants recruited from an enthusiast-leaning channel reported considerably greater benefits [of psychedelic use] than those recruited from a general-population platform. Even after controlling for mindset, setting, motivation, and personality, sample membership remained the strongest predictor of quality-of-life impact,” the study authors concluded.
“The persistent effect of sample membership suggests that the two groups differ in additional ways not captured by our measures, for example in cultural expectations, social context, or demographic composition, shaping reported outcomes. These results underscore the need for caution when interpreting findings from psychedelic studies that rely on highly engaged user populations.”
The study sheds light on important methodological issues that studies of psychedelic effects face. However, the authors note some limitations. For example, the two groups had demographic differences; the general sample was overwhelmingly from the United States, while the enthusiast sample lacked country-of-residence data for most participants (though a portion resided in Sweden). This introduces the possibility of cross-cultural differences influencing the results.
Additionally, it should be noted that the Prolific sample likely included many psychedelic enthusiasts as well. Because of this, the difference between the two groups in this study likely underestimates the true difference between the general population and psychedelic enthusiasts.
The paper, “Selection Bias in Psychedelic Research: Comparing Self-Reported Quality-Of-Life Impact Between Enthusiasts and a General Population Sample,” was authored by Jonathan Bendz, Linus Schäfer, David Sjöström, Sverker Sikström, and Petri Kajonius.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Psychedelics #SelectionBias #QualityOfLife #PsychedelicResearch #StudyBias #OpenMindedness #PersonalityTraits #MentalHealthResearch #TherapeuticPsychedelics #ScientificCaution
-
DATE: May 12, 2026 at 10:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Are the benefits of psychedelics exaggerated? A new study highlights the problem of selection bias
A study comparing psychedelic enthusiasts and people from the general population (who also had psychedelic experiences) found that the enthusiasts tended to report much greater positive quality-of-life effects. The enthusiasts also showed higher openness, extraversion, and agreeableness. This indicates that recruitment strategies in psychedelic research that lean towards including enthusiasts may shape the outcomes obtained in those studies. The paper was published in the Journal of Psychoactive Drugs.
Psychedelic drugs are substances that can strongly alter perception, mood, thinking, and the sense of self. They may change how people experience colors, sounds, time, memories, emotions, and the meaning of events. Classic psychedelics include LSD, psilocybin from “magic mushrooms,” DMT, and mescaline. These substances mainly act on serotonin receptors in the brain.
In research settings, psychedelics are being studied for possible therapeutic use in conditions such as depression, PTSD, anxiety, and substance use disorders. Their effects depend heavily on dose, personality, expectations, mental state, physical setting, and social support. Psychedelics can also carry risks, including panic, confusion, dangerous behavior during intoxication, worsening of some psychiatric conditions, and legal consequences where they are prohibited.
Study author Jonathan Bendz and his colleagues noted that many studies of psychedelic users report extraordinarily positive self-reported effects. However, they suggest that this might represent an exaggeration of the real effects caused by biased selection, or even self-selection, of study participants. The issue is that the effects of psychedelics can only be tested on individuals who agree to use them. These participants tend to be individuals who have already had especially positive experiences with psychedelic use.
To examine this hypothesis, these researchers conducted a study comparing whether the self-reported quality-of-life impact of psychedelic experiences differed between a convenience sample of psychedelic enthusiasts and a group of people from the general population recruited via Prolific. They also wanted to see whether the difference between the two groups remained after controlling for mindset, setting, motivation to use psychedelic drugs, and personality traits.
The enthusiast group consisted of 583 individuals recruited through an anonymous survey posted on the Facebook and Instagram pages of a Swedish nonprofit organization that disseminates information about psychedelic science (Nätverket för Psykedelisk Vetenskap). A snowball sampling approach was used to reach more participants. The general population group consisted of 599 individuals recruited via Prolific (an online survey platform). They were required to have prior psychedelic experience, but were not recruited from a specific psychedelic community.
Study participants completed assessments of the quality-of-life impact of their psychedelic experiences (e.g., “How has your most meaningful psychedelic experience affected the quality of your relationship with… family, friends, yourself, society, and nature?”). They also answered questions regarding their mindset and physical setting during the experience (“To what extent did you experience your mindset/environment to be optimal?”), their motivation (“What was your motivation for using a psychedelic substance?”), and their personality (using the IPIP-NEO-30 assessment).
Results showed that the psychedelic enthusiasts tended to report a much higher quality-of-life impact from their psychedelic experiences compared to the Prolific group. The enthusiast group also reported having a more optimal mindset and setting during their trips, and they were more likely to report taking the drugs for personal growth rather than for fun. Finally, the enthusiasts tended to be more open to new experiences, extraverted, and agreeable than the participants from the Prolific group.
Even after using a statistical model to account for these differences in personality, mindset, setting, and motivation, simply belonging to the enthusiast group remained the strongest predictor of reporting a high quality-of-life impact.
“As expected, participants recruited from an enthusiast-leaning channel reported considerably greater benefits [of psychedelic use] than those recruited from a general-population platform. Even after controlling for mindset, setting, motivation, and personality, sample membership remained the strongest predictor of quality-of-life impact,” the study authors concluded.
“The persistent effect of sample membership suggests that the two groups differ in additional ways not captured by our measures, for example in cultural expectations, social context, or demographic composition, shaping reported outcomes. These results underscore the need for caution when interpreting findings from psychedelic studies that rely on highly engaged user populations.”
The study sheds light on important methodological issues that studies of psychedelic effects face. However, the authors note some limitations. For example, the two groups had demographic differences; the general sample was overwhelmingly from the United States, while the enthusiast sample lacked country-of-residence data for most participants (though a portion resided in Sweden). This introduces the possibility of cross-cultural differences influencing the results.
Additionally, it should be noted that the Prolific sample likely included many psychedelic enthusiasts as well. Because of this, the difference between the two groups in this study likely underestimates the true difference between the general population and psychedelic enthusiasts.
The paper, “Selection Bias in Psychedelic Research: Comparing Self-Reported Quality-Of-Life Impact Between Enthusiasts and a General Population Sample,” was authored by Jonathan Bendz, Linus Schäfer, David Sjöström, Sverker Sikström, and Petri Kajonius.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Psychedelics #SelectionBias #QualityOfLife #PsychedelicResearch #StudyBias #OpenMindedness #PersonalityTraits #MentalHealthResearch #TherapeuticPsychedelics #ScientificCaution
-
Vidal Bustamante et al. found that the participants slept less than the minimum 8 hours of sleep recommended for their age group. https://www.acamh.org/research-digest/would-delaying-the-school-day-prevent-anxiety-in-adolescents #MentalHealthResearch #Anxiety
Would delaying the school day ... -
Thank you to the 20 participants that have taken part so far. Still need another 80 participants 🙏🏻 let's see if we can reach that target.
Participants must be #UK residents and be aged between 18-64.Link: https://mmu.eu.qualtrics.com/jfe/form/SV_es6NsOuhpxXYYtM
Please share if you can, would be greatly appreciated.
#researchstudy #ParticipantsWanted #Psychology #MentalHealth #Research #PsychologyStudy #MentalHealthResearch #DigitalWellbeing #UKResearch
-
Thank you to the 20 participants that have taken part so far. Still need another 80 participants 🙏🏻 let's see if we can reach that target.
Participants must be #UK residents and be aged between 18-64.Link: https://mmu.eu.qualtrics.com/jfe/form/SV_es6NsOuhpxXYYtM
Please share if you can, would be greatly appreciated.
#researchstudy #ParticipantsWanted #Psychology #MentalHealth #Research #PsychologyStudy #MentalHealthResearch #DigitalWellbeing #UKResearch
-
Thank you to the 20 participants that have taken part so far. Still need another 80 participants 🙏🏻 let's see if we can reach that target.
Participants must be #UK residents and be aged between 18-64.Link: https://mmu.eu.qualtrics.com/jfe/form/SV_es6NsOuhpxXYYtM
Please share if you can, would be greatly appreciated.
#researchstudy #ParticipantsWanted #Psychology #MentalHealth #Research #PsychologyStudy #MentalHealthResearch #DigitalWellbeing #UKResearch
-
Thank you to the 20 participants that have taken part so far. Still need another 80 participants 🙏🏻 let's see if we can reach that target.
Participants must be #UK residents and be aged between 18-64.Link: https://mmu.eu.qualtrics.com/jfe/form/SV_es6NsOuhpxXYYtM
Please share if you can, would be greatly appreciated.
#researchstudy #ParticipantsWanted #Psychology #MentalHealth #Research #PsychologyStudy #MentalHealthResearch #DigitalWellbeing #UKResearch
-
TRIGGER WARNING: Military Psychology
DATE: April 23, 2026 at 08:21AM
SOURCE: THE CENTER FOR DEPLOYMENT PSYCHOLOGYDirect article link at end of text block below.
The CDP team is celebrating a win! 🎉 Dr. Ally Grillo, a fellow at CDP received the “Best Translational Poster” award at the 2026 Brain, Behavior, and Mind Conference, hosted by the CSTS. #BrainBehaviorMind #MentalHealthResearch #PTSD #TranslationalScience
Articles can be found by scrolling down the page at https://deploymentpsych.org/ under "Latest News".
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #military #militarypsych #militarypsychology #militarycounseling #APA #Division19 #militaryhealth #DeploymentPsychology #UniformServicesUniversity
-
TRIGGER WARNING: Military Psychology
DATE: April 23, 2026 at 08:21AM
SOURCE: THE CENTER FOR DEPLOYMENT PSYCHOLOGYDirect article link at end of text block below.
The CDP team is celebrating a win! 🎉 Dr. Ally Grillo, a fellow at CDP received the “Best Translational Poster” award at the 2026 Brain, Behavior, and Mind Conference, hosted by the CSTS. #BrainBehaviorMind #MentalHealthResearch #PTSD #TranslationalScience
Articles can be found by scrolling down the page at https://deploymentpsych.org/ under "Latest News".
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #military #militarypsych #militarypsychology #militarycounseling #APA #Division19 #militaryhealth #DeploymentPsychology #UniformServicesUniversity
-
TRIGGER WARNING: Military Psychology
DATE: April 23, 2026 at 08:21AM
SOURCE: THE CENTER FOR DEPLOYMENT PSYCHOLOGYDirect article link at end of text block below.
The CDP team is celebrating a win! 🎉 Dr. Ally Grillo, a fellow at CDP received the “Best Translational Poster” award at the 2026 Brain, Behavior, and Mind Conference, hosted by the CSTS. #BrainBehaviorMind #MentalHealthResearch #PTSD #TranslationalScience
Articles can be found by scrolling down the page at https://deploymentpsych.org/ under "Latest News".
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #military #militarypsych #militarypsychology #militarycounseling #APA #Division19 #militaryhealth #DeploymentPsychology #UniformServicesUniversity
-
As part of my MSc Psychology at Manchester Met University, I’m studying how social media use relates to wellbeing in UK adults (18–64, active users). 10–15 min survey on active vs passive use, mood and wellbeing.
Do not participate if currently experiencing mental health problems.
https://mmu.eu.qualtrics.com/jfe/form/SV_es6NsOuhpxXYYtM#CallForParticipants #PsychologyStudy #ResearchStudy #MentalHealthResearch #DigitalWellbeing #SocialMediaUse #UKParticipants #Wellbeing #SurveyParticipants #MScPsychology
-
As part of my MSc Psychology at Manchester Met University, I’m studying how social media use relates to wellbeing in UK adults (18–64, active users). 10–15 min survey on active vs passive use, mood and wellbeing.
Do not participate if currently experiencing mental health problems.
https://mmu.eu.qualtrics.com/jfe/form/SV_es6NsOuhpxXYYtM#CallForParticipants #PsychologyStudy #ResearchStudy #MentalHealthResearch #DigitalWellbeing #SocialMediaUse #UKParticipants #Wellbeing #SurveyParticipants #MScPsychology
-
As part of my MSc Psychology at Manchester Met University, I’m studying how social media use relates to wellbeing in UK adults (18–64, active users). 10–15 min survey on active vs passive use, mood and wellbeing.
Do not participate if currently experiencing mental health problems.
https://mmu.eu.qualtrics.com/jfe/form/SV_es6NsOuhpxXYYtM#CallForParticipants #PsychologyStudy #ResearchStudy #MentalHealthResearch #DigitalWellbeing #SocialMediaUse #UKParticipants #Wellbeing #SurveyParticipants #MScPsychology
-
As part of my MSc Psychology at Manchester Met University, I’m studying how social media use relates to wellbeing in UK adults (18–64, active users). 10–15 min survey on active vs passive use, mood and wellbeing.
Do not participate if currently experiencing mental health problems.
https://mmu.eu.qualtrics.com/jfe/form/SV_es6NsOuhpxXYYtM#CallForParticipants #PsychologyStudy #ResearchStudy #MentalHealthResearch #DigitalWellbeing #SocialMediaUse #UKParticipants #Wellbeing #SurveyParticipants #MScPsychology
-
As part of my MSc Psychology at Manchester Met University, I’m studying how social media use relates to wellbeing in UK adults (18–64, active users). 10–15 min survey on active vs passive use, mood and wellbeing.
Do not participate if currently experiencing mental health problems.
https://mmu.eu.qualtrics.com/jfe/form/SV_es6NsOuhpxXYYtM#CallForParticipants #PsychologyStudy #ResearchStudy #MentalHealthResearch #DigitalWellbeing #SocialMediaUse #UKParticipants #Wellbeing #SurveyParticipants #MScPsychology
-
To do so, they studied a large cohort of about 4,700 teenagers. https://www.acamh.org/research-digest/insufficient-sleep-during-adolescence-might-pose-a-risk-for-later-depression-and-anxiety #MentalHealthResearch #Anxiety #Depression
Insufficient sleep during adol... -
https://www.europesays.com/uk/908407/ Experts in Bengaluru call for dedicated department for research on mental health apps | Bengaluru News #BengaluruLatestNews #BengaluruNews #BengaluruNewsLive #BengaluruNewsToday #DigitalInterventions #DigitalMentalHealth #Health #MentalHealth #MentalHealthApps #MentalHealthResearch #NIMHANS #TodayNewsBengaluru #UK #UnitedKingdom
-
Experts in Bengaluru call for dedicated department for research on mental health apps | Bengaluru News
Bengaluru: Mental health experts emphasised the need for a full-fledged department or centre for applied res…
#NewsBeep #News #Mentalhealth #Bengalurulatestnews #Bengalurunews #Bengalurunewslive #Bengalurunewstoday #CA #Canada #digitalinterventions #digitalmentalhealth #Health #mentalhealthapps #mentalhealthresearch #MentalHealth #NIMHANS #TodaynewsBengaluru
https://www.newsbeep.com/ca/617241/ -
Experts in Bengaluru call for dedicated department for research on mental health apps | Bengaluru News
Bengaluru: Mental health experts emphasised the need for a full-fledged de…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #bengalurulatestnews #Bengalurunews #Bengalurunewslive #Bengalurunewstoday #digitalinterventions #digitalmentalhealth #Health #mentalhealthapps #mentalhealthresearch #MentalHealth #NIMHANS #TodaynewsBengaluru
https://www.newsbeep.com/us/595965/ -
Experts in Bengaluru call for dedicated department for research on mental health apps | Bengaluru News
Bengaluru: Mental health experts emphasised the need for a full-fledged de…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #bengalurulatestnews #Bengalurunews #Bengalurunewslive #Bengalurunewstoday #digitalinterventions #digitalmentalhealth #Health #mentalhealthapps #mentalhealthresearch #MentalHealth #NIMHANS #TodaynewsBengaluru
https://www.newsbeep.com/us/595965/ -
Experts in Bengaluru call for dedicated department for research on mental health apps | Bengaluru News
Bengaluru: Mental health experts emphasised the need for a full-fledged department or centre for applied …
#NewsBeep #News #Mentalhealth #AU #Australia #Bengalurulatestnews #Bengalurunews #Bengalurunewslive #Bengalurunewstoday #digitalinterventions #digitalmentalhealth #Health #mentalhealthapps #mentalhealthresearch #MentalHealth #NIMHANS #TodaynewsBengaluru
https://www.newsbeep.com/au/619537/ -
Experts in Bengaluru call for dedicated department for research on mental health apps | Bengaluru News
Bengaluru: Mental health experts emphasised the need for a full-fledged department or centre for applied …
#NewsBeep #News #Mentalhealth #AU #Australia #Bengalurulatestnews #Bengalurunews #Bengalurunewslive #Bengalurunewstoday #digitalinterventions #digitalmentalhealth #Health #mentalhealthapps #mentalhealthresearch #MentalHealth #NIMHANS #TodaynewsBengaluru
https://www.newsbeep.com/au/619537/ -
https://www.europesays.com/ie/444958/ Experts in Bengaluru call for dedicated department for research on mental health apps | Bengaluru News #BengaluruLatestNews #BengaluruNews #BengaluruNewsLive #BengaluruNewsToday #DigitalInterventions #DigitalMentalHealth #Éire #Health #IE #Ireland #MentalHealth #MentalHealthApps #MentalHealthResearch #MentalHealth #NIMHANS #TodayNewsBengaluru
-
📄 In #CAMH: “All that I've been through has made me who I am”: youth conceptualisations of personal recovery in mental health
👉 https://doi.org/10.1111/camh.70046
#MentalHealthResearch -
📄 In #CAMH: Technology matters: AI‐driven tools in children's mental healthcare: perspectives from young people and parents
👉 https://doi.org/10.1111/camh.70045
#MentalHealthResearch -
📄 In #JCPPA: Genetic and environmental influences on sleep quality, ability to settle, and crying duration in 2‐ and 5‐month‐old infants: A longitudinal twin study
👉 https://doi.org/10.1002/jcv2.70023
#MentalHealthResearch #Autism #SleepDisorders -
CW: Sensitive topic: child/adolescent mental health
In #CAMH: Review: Adolescents' perspectives on and experiences with post‐primary school‐based suicide prevention as end‐users, co‐creators and peer helpers – a systematic review meta‐ethnography
👉 https://doi.org/10.1111/camh.70043
#MentalHealthResearch #ResearchReview #Suicide -
📄 In #JCPP: Editorial Perspective: Smoking, vaping and mental health – a perspective on potential causal mechanisms
👉 https://doi.org/10.1111/jcpp.70059
#MentalHealthResearch #Editorial #SubstanceUse -
📄 In #CAMH: The effectiveness of an online‐based psychosocial program for parents of children with neurodevelopmental disorders – a randomized controlled trial
👉 https://doi.org/10.1111/camh.70044
#MentalHealthResearch #ADHD #Autism -
📄 In #CAMH: Editorial Perspective: A call for action on imposter participants in child and adolescent mental health research
👉 https://doi.org/10.1111/camh.70041
#MentalHealthResearch #EvidenceBased #Editorial